Clinical Trials

• F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response
  ClinicalTrials.gov Identifier: NCT00180193 - Recruiting
  Brain Tumor
  
• Fabry : National Initiative of Screening
  ClinicalTrials.gov Identifier: NCT00484549 - Recruiting
  Ischemic Stroke Hospitalized
  
• Fabry Disease Registry
  ClinicalTrials.gov Identifier: NCT00196742 - Recruiting
  Fabry Disease
  
• FAC Vs.FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative Hight Risk Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00129389 - Recruiting
  Breast cancer.
  
• FACBC PET/CT for Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00562315 - Recruiting
  Prostate Cancer
  
• Face Reconstruction by Allotransplantation of Composite Tissues
  ClinicalTrials.gov Identifier: NCT00527280 - Recruiting
  for the Reconstruction of the Face
  
• Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
  ClinicalTrials.gov Identifier: NCT00360932 - Active, not recruiting
  Facial Lipoatrophy
  
• Facial Lipoatrophy Trial
  ClinicalTrials.gov Identifier: NCT00126308 - Active, not recruiting
  HIV-Associated Lipodystrophy
  
• Facial Thermography Study of Levocetirizine Versus Cetirizine
  ClinicalTrials.gov Identifier: NCT00150761 - Completed
  Anti-allergic Agents
  
• Facilitated Referral for Children Screening Positive for Mental Illness
  ClinicalTrials.gov Identifier: NCT00448331 - Completed
  Mental Disorders; Mentally Ill Persons; Emergency Medicine
  
• Facilitating Aftercare for Alcohol Detox Patients
  ClinicalTrials.gov Identifier: NCT00513708 - Recruiting
  Alcohol Abuse; Alcohol Dependence
  
• Facilitating Implementation of the Public Health Service (PHS) Smoking Cessation Guideline
  ClinicalTrials.gov Identifier: NCT00057070 - Completed
  Smoking Cessation; Randomized Controlled Trial
  
• Facilitating Shared Decision Making About Prostate Cancer Screening
  ClinicalTrials.gov Identifier: NCT00013247 - Completed
  Prostate Cancer
  
• Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs
  ClinicalTrials.gov Identifier: NCT00137306 - Completed
  Mood Disorders; Substance-Related Disorders
  
• Facilitation and Barriers to Breastfeeding in the NICU
  ClinicalTrials.gov Identifier: NCT00527956 - Not yet recruiting
  Breastfeeding; Prematurity
  
• Facilitation of NMDA Receptor Function in Patients With Schizophrenia and co-Morbid Alcoholism
  ClinicalTrials.gov Identifier: NCT00338598 - Recruiting
  Alcoholism; Schizophrenia
  
• Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients with Dysphagia
  ClinicalTrials.gov Identifier: NCT00001718 - Completed
  Deglutition Disorders; dysphagia
  
• Facilitators to Keeping Colonoscopy Appointments
  ClinicalTrials.gov Identifier: NCT00431327 - Completed
  Healthy
  
• FACT - Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy
  ClinicalTrials.gov Identifier: NCT00256698 - Recruiting
  Breast Cancer
  
• Factor IX Inhibition in Thrombosis Prevention (the FIXIT Trial)
  ClinicalTrials.gov Identifier: NCT00119457 - Active, not recruiting
  Venous Thromboembolism; Embolism and Thrombosis; Hip Fractures
  
• Factor V Leiden Mutation and Implantation Failure
  ClinicalTrials.gov Identifier: NCT00194350 - Active, not recruiting
  Infertility
  
• Factor VIIa in Acute Intracerebral Haemorrhage
  ClinicalTrials.gov Identifier: NCT00266006 - Completed
  Intracerebral Haemorrhage
  
• Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
  ClinicalTrials.gov Identifier: NCT00408239 - Recruiting
  Thromboembolism
  
• Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
  ClinicalTrials.gov Identifier: NCT00353678 - Completed
  Thromboembolism
  
• Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)
  ClinicalTrials.gov Identifier: NCT00375609 - Completed
  Thromboembolism
  
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00073424 - Active, not recruiting
  HIV Infections
  
• Factors Affecting Caloric Regulation in Human Feeding
  ClinicalTrials.gov Identifier: NCT00108784 - Completed
  Obesity
  
• Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women
  ClinicalTrials.gov Identifier: NCT00519974 - Recruiting
  Breast Cancer; Psychosocial Effects/Treatment
  
• Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00019643 - Active, not recruiting
  Depression; Stage I Breast Cancer; Stage IIIA Breast Cancer; Nutrition; Stage II Breast Cancer; Psychosocial Effects/Treatment; Quality of Life
  
• Factors Associated to Success of Hepatitis C Therapy
  ClinicalTrials.gov Identifier: NCT00514111 - Recruiting
  Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
  
• Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study
  ClinicalTrials.gov Identifier: NCT00415415 - Completed
  Cardiovascular Diseases; Coronary Disease
  
• Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00401908 - Recruiting
  Acute Gastrointestinal Bleeding; Acute Coronary Syndrome
  
• Factors Contributing to Increased Left Ventricle Size in Patients with Abnormally Enlarged Hearts
  ClinicalTrials.gov Identifier: NCT00001878 - Completed
  Hypertrophic Cardiomyopathy; Left Ventricular Hypertrophy
  
• Factors Determining Outcomes in Patients with Graft-Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00092235 - Recruiting
  
  
• Factors in Childhood Lung Susceptibility to Pollution
  ClinicalTrials.gov Identifier: NCT00233285 - Active, not recruiting
  Lung Diseases; Asthma
  
• Factors Involved in Asthma and Airway Inflammation
  ClinicalTrials.gov Identifier: NCT00001887 - Completed
  Asthma; Healthy
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto
  ClinicalTrials.gov Identifier: NCT00327639 - Recruiting
  Thalassemia; Fertility; Pregnancy
  
• Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00223457 - Completed
  Multiple Sclerosis
  
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00064441 - Completed
  Ulcerative Colitis
  
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00064454 - Completed
  Ulcerative Colitis
  
• Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes
  ClinicalTrials.gov Identifier: NCT00163956 - Recruiting
  DVT; PE
  
• Failure of Implantation After Recurrent Embryo Transfers
  ClinicalTrials.gov Identifier: NCT00351481 - Recruiting
  Infertility
  
• Failure Time Methods for Family Disease Studies
  ClinicalTrials.gov Identifier: NCT00037232 - Completed
  Heart Diseases; Cardiovascular Diseases; Coronary Disease
  
• Fall Prevention and Music Therapy
  ClinicalTrials.gov Identifier: NCT00121693 - Completed
  Accidental Falls; Healthy
  
• Fall Prevention by Alfacalcidol and Training
  ClinicalTrials.gov Identifier: NCT00483275 - Not yet recruiting
  Accidental Falls; Chronic Renal Insufficiency; Aged
  
• Fall Prevention in a Geriatric Nursing Home Setting Using the Music of Nolwenn Leroy
  ClinicalTrials.gov Identifier: NCT00272272 - Completed
  Falls
  
• Fall Prevention in Osteoporosis
  ClinicalTrials.gov Identifier: NCT00432692 - Recruiting
  Osteoporosis
  
• Fall Prevention Strategies Including Music and Posturography
  ClinicalTrials.gov Identifier: NCT00368511 - Recruiting
  Fall Prevention
  
• Falls in Stroke Patients After Hospital Discharge: Prevalence and Risk Factors
  ClinicalTrials.gov Identifier: NCT00167063 - Active, not recruiting
  Stroke
  
• Famciclovir (Famvir) Oral Pediatric Formulation in Children 1-12 Years of Age with Varicella Zoster Infection
  ClinicalTrials.gov Identifier: NCT00098046 - Completed
  Chickenpox; Herpes Zoster
  
• Familial Aggregation and Natural History of Sleep Apnea
  ClinicalTrials.gov Identifier: NCT00005299 - Active, not recruiting
  Lung Diseases; Sleep Apnea Syndromes
  
• Familial Aggregation of Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00058877 - Completed
  Barrett's Esophagus; Esophageal Neoplasm
  
• Familial Aggregation of Stress Response
  ClinicalTrials.gov Identifier: NCT00005428 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Familial Amyotrophic Lateral Sclerosis. A Preliminary Study to Identify Subjects Who Might Be Willing to Participate in a Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00136500 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Familial Atherosclerosis Treatment Study (FATS)
  ClinicalTrials.gov Identifier: NCT00000512 - Completed
  Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia
  
• Familial Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00288119 - Recruiting
  Barrett's Esophagus; Esophageal Neoplasm
  
• Familial Intracranial Aneurysm Study
  ClinicalTrials.gov Identifier: NCT00071565 - Active, not recruiting
  Intracranial Aneurysm; Subarachnoid Hemorrhage
  
• Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
  ClinicalTrials.gov Identifier: NCT00001373 - Recruiting
  Periodic Disease
  
• Familial Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00001377 - Completed
  Neoplastic Syndromes, Hereditary; Prostatic Neoplasms
  
• Families Coping With Mental Illness Program
  ClinicalTrials.gov Identifier: NCT00435721 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Families In Recovery From Stroke Trial (F.I.R.S.T.)
  ClinicalTrials.gov Identifier: NCT00037492 - Completed
  Stroke
  
• Family and Peer Involvement in the Treatment of Anxiety Disorders in Children
  ClinicalTrials.gov Identifier: NCT00073645 - Recruiting
  Anxiety Disorders
  
• Family Approach to Managing Asthma in Early Teens
  ClinicalTrials.gov Identifier: NCT00241852 - Recruiting
  Asthma; Lung Diseases
  
• Family Atherosclerosis Counseling and Testing Project
  ClinicalTrials.gov Identifier: NCT00387595 - Completed
  Coronary Artery Disease
  
• Family Based Interventions: Preschool Children and Parent
  ClinicalTrials.gov Identifier: NCT00024843 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Family Based Treatment of Early Childhood Obsessive Compulsive Disorder (OCD)
  ClinicalTrials.gov Identifier: NCT00055068 - Recruiting
  Obsessive Compulsive Disorder (OCD)
  
• Family Blood Pressure Program - GenNet Network
  ClinicalTrials.gov Identifier: NCT00005268 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Family Blood Pressure Program - GENOA
  ClinicalTrials.gov Identifier: NCT00005269 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Coronary Arteriosclerosis
  
• Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)
  ClinicalTrials.gov Identifier: NCT00234260 - Terminated
  Arteriosclerosis; Hypertension; Heart Diseases
  
• Family Blood Pressure Program - HyperGEN
  ClinicalTrials.gov Identifier: NCT00005267 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Family Blood Pressure Program - SAPPHIRe Network
  ClinicalTrials.gov Identifier: NCT00005270 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Family Cognitive Behavioral Therapy for Preventing Depression in Children
  ClinicalTrials.gov Identifier: NCT00183482 - Recruiting
  Depression
  
• Family Connections Weight Management
  ClinicalTrials.gov Identifier: NCT00433901 - Active, not recruiting
  Childhood Obesity
  
• Family Consultation for Health-Compromised Smokers
  ClinicalTrials.gov Identifier: NCT00400751 - Completed
  Nicotine Dependence
  
• Family Dietary Coaching to Improve Nutritional Intakes and Body Weight Control
  ClinicalTrials.gov Identifier: NCT00456911 - Completed
  Primary Prevention; Obesity Prevention; Body Weight Control
  
• Family Health After Predictive Huntington Disease (HD) Testing
  ClinicalTrials.gov Identifier: NCT00075140 - Recruiting
  Huntington Disease
  
• Family Health Study (Validation of a Family History of Cancer Questionnaire for Risk Factor Surveillance)
  ClinicalTrials.gov Identifier: NCT00341757 - Active, not recruiting
  Cancer
  
• Family Heart Health Program: Randomized, Controlled Trial
  ClinicalTrials.gov Identifier: NCT00552591 - Recruiting
  Coronary Heart Disease
  
• Family Heart Study (FHS)
  ClinicalTrials.gov Identifier: NCT00005136 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis; Coronary Disease; Heart Diseases
  
• Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
  ClinicalTrials.gov Identifier: NCT00024596 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Arteriosclerosis
  
• Family Help Program: Nighttime Enuresis Treatment Program
  ClinicalTrials.gov Identifier: NCT00270621 - Active, not recruiting
  Enuresis
  
• Family Help Program: Pediatric Anxiety
  ClinicalTrials.gov Identifier: NCT00267566 - Active, not recruiting
  Anxiety Disorder
  
• Family Help Program: Pediatric Attention Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00267605 - Active, not recruiting
  Attention Deficit/Hyperactivity Disorder
  
• Family Help Program: Pediatric Disruptive Behaviour Disorder
  ClinicalTrials.gov Identifier: NCT00267579 - Active, not recruiting
  Child Behaviour
  
• Family Help Program: Pediatric Recurrent Headache and Abdominal Pain
  ClinicalTrials.gov Identifier: NCT00267618 - Active, not recruiting
  Recurrent Pain
  
• Family History in Prostate Cancer Patients in Taiwan
  ClinicalTrials.gov Identifier: NCT00155025 - Recruiting
  Prostate Cancer
  
• Family Intervention for Mental Illness and Substance Abuse
  ClinicalTrials.gov Identifier: NCT00043693 - Active, not recruiting
  Mental Disorders; Substance-Related Disorders; Psychotic Disorders
  
• Family Intervention for Suicidal Youth: Emergency Care
  ClinicalTrials.gov Identifier: NCT00558805 - Completed
  Suicide, Attempted
  
• Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
  ClinicalTrials.gov Identifier: NCT00342927 - Recruiting
  Nephropathy; Diabetes
  
• Family Involvement in The Treatment Of a Mentally Ill Relative
  ClinicalTrials.gov Identifier: NCT00258167 - Not yet recruiting
  Families of Mentally Ill
  
• Family Lifestyle Overweight Prevention Program
  ClinicalTrials.gov Identifier: NCT00454610 - Active, not recruiting
  Overweight; Obesity
  
• Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
  ClinicalTrials.gov Identifier: NCT00083798 - Active, not recruiting
  Sleep Apnea Syndromes; Lung Diseases; Insulin Resistance
  
• Family Management of Childhood Diabetes Study
  ClinicalTrials.gov Identifier: NCT00340938 - Active, not recruiting
  Diabetes; Type 1 Diabetes
  
• Family Management of Type 1 Diabetes in Children
  ClinicalTrials.gov Identifier: NCT00273286 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Family Myopia Study
  ClinicalTrials.gov Identifier: NCT00341549 - Recruiting
  Myopia
  
• Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
  ClinicalTrials.gov Identifier: NCT00287027 - Terminated
  Psychotic Disorders
  
• Family Preparation Study For Withdrawal of Mechanical Ventilation From Their Family Member
  ClinicalTrials.gov Identifier: NCT00214344 - Completed
  Mechanical Ventilation; Critically Ill
  
• Family Process, Adherence, and Child Asthma Outcome
  ClinicalTrials.gov Identifier: NCT00005390 - Completed
  Asthma; Lung Diseases
  
• Family Psychoeducation for Children with Mood Disorders
  ClinicalTrials.gov Identifier: NCT00050557 - Active, not recruiting
  Mood Disorders
  
• Family Quality of Life Among Families With a Member Who is a Cancer Patient
  ClinicalTrials.gov Identifier: NCT00544336 - Recruiting
  Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
  ClinicalTrials.gov Identifier: NCT00181792 - Recruiting
  ADHD; Smoking
  
• Family Spirit Study
  ClinicalTrials.gov Identifier: NCT00356551 - Completed
  Substance Abuse
  
• Family Studies in Primary Biliary Cirrhosis (PBC)
  ClinicalTrials.gov Identifier: NCT00242125 - Recruiting
  Biliary Cirrhosis, Primary
  
• Family Studies of Eye Traits
  ClinicalTrials.gov Identifier: NCT00342342 - Active, not recruiting
  Cataracts; Ocular Refraction; Glaucoma
  
• Family Studies of Inherited Heart Disease
  ClinicalTrials.gov Identifier: NCT00001225 - Completed
  Hypertrophic Cardiomyopathy
  
• Family Studies of Uveal Coloboma
  ClinicalTrials.gov Identifier: NCT00368004 - Recruiting
  Coloboma
  
• Family Study in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00418912 - Not yet recruiting
  Schizophrenia; Family; Genetics
  
• Family Study of Affective and Anxiety Spectrum Disorders
  ClinicalTrials.gov Identifier: NCT00071786 - Recruiting
  Mood DIsorders; Anxiety Disorders
  
• Family Study of Congenital Cardiovascular Malformations
  ClinicalTrials.gov Identifier: NCT00005258 - Completed
  Cardiovascular Diseases; Defect, Congenital Heart; Heart Diseases
  
• Family Study of Head and Neck Cancers in Taiwan
  ClinicalTrials.gov Identifier: NCT00342147 - Active, not recruiting
  Nasopharyngeal Carcinoma
  
• Family Study of Melanoma in Italy
  ClinicalTrials.gov Identifier: NCT00339222 - Recruiting
  Melanoma
  
• Family Study on Preeclampsia
  ClinicalTrials.gov Identifier: NCT00344162 - Completed
  Preeclampsia
  
• Family Therapy for Adolescent Bulimia Nervosa
  ClinicalTrials.gov Identifier: NCT00518843 - Completed
  Bulimia Nervosa
  
• Family Workshops for Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00296283 - Completed
  Bipolar Disorder
  
• Family-Based HIV Prevention for Adolescent Girls
  ClinicalTrials.gov Identifier: NCT00243126 - Completed
  HIV Infections
  
• Family-Based HIV Prevention for Latinos
  ClinicalTrials.gov Identifier: NCT00582101 - Recruiting
  HIV Infections
  
• Family-Based Nutrition Intervention for Latino Children
  ClinicalTrials.gov Identifier: NCT00224887 - Active, not recruiting
  Obesity; Heart Diseases
  
• Family-Based Prevention Program for Childhood Anxiety
  ClinicalTrials.gov Identifier: NCT00078728 - Active, not recruiting
  Anxiety Disorders
  
• Family-Centered Behavioral Preparation for Surgery
  ClinicalTrials.gov Identifier: NCT00261261 - Completed
  Anxiety
  
• Family-Centered Diabetes Project
  ClinicalTrials.gov Identifier: NCT00006159 - Completed
  Diabetes
  
• Family-Centered Diabetes Project - Sharing Wisdom
  ClinicalTrials.gov Identifier: NCT00438126 - Completed
  Prediabetes; Metabolic Syndrome; Overweight; Obesity
  
• Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00434980 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
  
• Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma
  ClinicalTrials.gov Identifier: NCT00384813 - Not yet recruiting
  Asthma
  
• Family-Supported Smoking Cessation for Chronically Ill Veterans
  ClinicalTrials.gov Identifier: NCT00448344 - Not yet recruiting
  Chronic Disease; Neoplasm; Cardiovascular Disease
  
• Famotidine in Subjects with Non-Erosive Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00141960 - Completed
  Gastroesophageal Reflux; Gastrointestinal Diseases; Reflux, Gastroesophageal; GERD
  
• Famvir (famciclovir) Pediatric Formulation in Children 1-12 Years of Age with Herpes Simplex Infection
  ClinicalTrials.gov Identifier: NCT00098059 - Completed
  Herpes Simplex
  
• Fanconi Syndrome Due to ARVs in HIV-Infected Persons
  ClinicalTrials.gov Identifier: NCT00499187 - Recruiting
  HIV Infections; Fanconi Syndrome; Kidney Disease; Renal Impairment
  
• Fangshan / Family-Based Ischemic Stroke Study In China
  ClinicalTrials.gov Identifier: NCT00534742 - Recruiting
  Stroke
  
• Far Infrared Radiation Treatment for Bipolar Condition
  ClinicalTrials.gov Identifier: NCT00573196 - Active, not recruiting
  Bipolar Disorder
  
• Far Infrared Radiation Treatment for Diabetes
  ClinicalTrials.gov Identifier: NCT00573456 - Active, not recruiting
  Diabetes Mellitus
  
• Far Infrared Radiation Treatment for Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00573352 - Active, not recruiting
  Osteoarthritis
  
• Far Infrared Radiation Treatment for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00573820 - Active, not recruiting
  Prostatic Neoplasms
  
• Far Infrared Radiation Treatment for Uterine Fibroids
  ClinicalTrials.gov Identifier: NCT00574418 - Active, not recruiting
  Leiomyoma
  
• Far Infrared Radiation Treatment of Dementia and Other Mental Illness
  ClinicalTrials.gov Identifier: NCT00574054 - Not yet recruiting
  Dementia
  
• Farming and Movement Evaluation Study (FAME)
  ClinicalTrials.gov Identifier: NCT00042120 - Completed
  Parkinson's Disease; Movement Disorders
  
• Farmwork & Preterm Low Birthweight Among Hispanic Women
  ClinicalTrials.gov Identifier: NCT00015613 - Completed
  Infant, Low Birth Weight; Infant, Premature, Diseases
  
• Farnesyl Protein Transferase Inhibitor (FPTI) in Combination with Docetaxel in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00040547 - Completed
  Neoplasms
  
• Fascia Iliaca Compartment Blockade as Analgesia for Hip Fractures in the Acute Phase
  ClinicalTrials.gov Identifier: NCT00162630 - Completed
  Hip Fracture
  
• Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
  ClinicalTrials.gov Identifier: NCT00328120 - Active, not recruiting
  Advanced Breast Cancer
  
• Faslodex Advanced Breast Cancer Local Chinese Study
  ClinicalTrials.gov Identifier: NCT00327769 - Completed
  Advanced Breast Cancer
  
• FASLODEX and AROMASIN in Hormone Receptor Positive Postmenopausal Women with Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00065325 - Active, not recruiting
  Breast Neoplasms; Metastases, Neoplasm
  
• Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients
  ClinicalTrials.gov Identifier: NCT00241462 - Active, not recruiting
  Breast Cancer
  
• FAST (Fluid Accumulation Status Trial)
  ClinicalTrials.gov Identifier: NCT00289276 - Recruiting
  Congestive Heart Failure; Cardiomyopathy; Dyspnea; Pulmonary Edema; Heart Diseases
  
• Fast Assessment of Stroke and Transient ischemic attack to prevent Early Recurrence (FASTER)
  ClinicalTrials.gov Identifier: NCT00109382 - Completed
  Transient Ischemic Attack; Stroke
  
• Fast Food Feeding in Youth
  ClinicalTrials.gov Identifier: NCT00121706 - Completed
  Obesity
  
• Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers
  ClinicalTrials.gov Identifier: NCT00233311 - Recruiting
  Heart Diseases; Diabetes; Obesity
  
• Fast Stepping in Stroke Patients for Fall Prediction and Prevention:Control Mechanisms and Clinical Implications
  ClinicalTrials.gov Identifier: NCT00167037 - Active, not recruiting
  Stroke
  
• Fast Titration in the Treatment of Schizophrenia, Taiwan
  ClinicalTrials.gov Identifier: NCT00304473 - Completed
  Schizophrenia
  
• Fast Titration Of Quetiapine Versus Currently Approved Titration
  ClinicalTrials.gov Identifier: NCT00254813 - Completed
  Psychotic Disorders
  
• Fast Track Admittance of Hip Fracture Patients
  ClinicalTrials.gov Identifier: NCT00345488 - Active, not recruiting
  Hip Fracture
  
• Fast Track CSII Using a Novel Device in Young Children With Newly Diagnosed T1DM
  ClinicalTrials.gov Identifier: NCT00476788 - Recruiting
  Type 1 Diabetes Mellitus
  
• Fast Track in Open Colonic Surgery - A Multicentric Randomized Controlled Trial
  ClinicalTrials.gov Identifier: NCT00556790 - Terminated
  Elective Colectomie; Median Laparotomie
  
• FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
  ClinicalTrials.gov Identifier: NCT00486798 - Recruiting
  Psychotic Disorders; Schizophrenia; Bipolar Disorder
  
• Fast-Track Diagnosis for Lung Cancer Suspects With PET-CT and EUS
  ClinicalTrials.gov Identifier: NCT00556647 - Recruiting
  Lung Cancer
  
• Fast-Track vs Conventional for UKA
  ClinicalTrials.gov Identifier: NCT00284635 - Completed
  Unicompartmental Knee Replacement
  
• FASTT Trial -- Conventional Infertility Treatment vs. Fast Track to IVF
  ClinicalTrials.gov Identifier: NCT00260091 - Active, not recruiting
  Infertility
  
• Fat Cell Size in Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00341406 - Recruiting
  Obesity; Adipose Cell Turn Over
  
• Fat Distribution in Healthy Early Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00335218 - Completed
  Healthy; Postmenopausal Period
  
• Fat Reduction Intervention Trial in African-Americans
  ClinicalTrials.gov Identifier: NCT00005700 - Completed
  Cardiovascular Diseases; Coronary Heart Disease Risk Reduction; Heart Diseases
  
• Fat Tissue Microperfusion to Measure Leptin Secretion and its Relations with Fat Breakdown in Humans
  ClinicalTrials.gov Identifier: NCT00001722 - Completed
  Healthy; Obesity
  
• Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
  ClinicalTrials.gov Identifier: NCT00278928 - Terminated
  Hypertriglyceridemia
  
• FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
  ClinicalTrials.gov Identifier: NCT00383136 - Recruiting
  Acute Myocardial Infarction
  
• Fatigue and Cancer Treatment(FACT)- an Exercise Intervention
  ClinicalTrials.gov Identifier: NCT00181129 - Recruiting
  Cancer,; Fatigue
  
• Fatigue and Symptom Burden in Febrile Neutropenia
  ClinicalTrials.gov Identifier: NCT00503854 - Recruiting
  Solid Tumors; Febrile Neutropenia
  
• Fatigue Experience in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00450541 - Recruiting
  Cancer
  
• Fatigue in Breast Cancer: A Behavioral Sleep Intervention
  ClinicalTrials.gov Identifier: NCT00572416 - Completed
  Breast Cancer
  
• Fatigue in Emergency Center Patients
  ClinicalTrials.gov Identifier: NCT00504985 - Active, not recruiting
  Advanced Cancer; Hematologic Malignancy; Fatigue
  
• Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
  ClinicalTrials.gov Identifier: NCT00342381 - Completed
  Multiple Sclerosis; Fatigue
  
• Fatigue Intervention Trial for Breast Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00513136 - Recruiting
  Fatigue
  
• Fatigue Treatment Using Provigil
  ClinicalTrials.gov Identifier: NCT00220506 - Recruiting
  All Multiple Sclerosis patients
  
• Fatty Acid Antiarrhythmia Trial (FAAT)
  ClinicalTrials.gov Identifier: NCT00004559 - Completed
  Arrhythmia; Heart Diseases; Tachycardia, Ventricular; Ventricular Fibrillation
  
• Fatty Acid Binding Protein 2 (FABP2) Ancillary Proposal
  ClinicalTrials.gov Identifier: NCT00256633 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns
  ClinicalTrials.gov Identifier: NCT00362089 - Recruiting
  Overweight; Obesity
  
• Fatty Acids in Neurological Development of Formula Fed Infants
  ClinicalTrials.gov Identifier: NCT00222157 - Active, not recruiting
  Normality
  
• Fatty Liver in Chronic Hepatitis C (HCV): Is There a Difference in Oxidative Stress and Inflammation Compared to HCV Without Fatty Liver?
  ClinicalTrials.gov Identifier: NCT00444002 - Recruiting
  Hepatitis C; Steatosis or no Steatosis
  
• Fatty Liver in Pregnancy
  ClinicalTrials.gov Identifier: NCT00471575 - Not yet recruiting
  Fatty Liver
  
• Fatty Liver in Taiwanese Children
  ClinicalTrials.gov Identifier: NCT00274183 - Not yet recruiting
  Fatty Liver
  
• FCM Versus R-FCM Followed by R-Maintenance or Observation Only
  ClinicalTrials.gov Identifier: NCT00317096 - Active, not recruiting
  Lymphoma, Follicular; Lymphoma, Low-Grade; Lymphoma, Intermediate-Grade
  
• FCR and Bevacizumab in the Treatment of Relapsed CLL
  ClinicalTrials.gov Identifier: NCT00448019 - Recruiting
  Chronic Lymphocytic Leukemia
  
• FCR Plus Sargramostim (GM-CSF) as Frontline Therapy in Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00381004 - Recruiting
  Chronic Lymphocytic Leukemia; Leukemia
  
• FDA Phase IV - Commitment - Retinal Function Study
  ClinicalTrials.gov Identifier: NCT00461565 - Completed
  Healthy
  
• FDG PET-CT in Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00282906 - Recruiting
  Prostate Cancer
  
• FDG-PET Imaging in Complicated Diabetic Foot
  ClinicalTrials.gov Identifier: NCT00194298 - Recruiting
  Diabetic Foot Disease
  
• FDG-PET Imaging in Painful Joint Prosthesis
  ClinicalTrials.gov Identifier: NCT00194285 - Recruiting
  Painful Joint Prostheses
  
• FDG-PET in Helping Doctors Plan Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00564733 - Recruiting
  Lung Cancer
  
• FDG-PET to Investigate SGN-15 and Docetaxel in Patients with Advanced Non-Small Cell Lung Carcinoma
  ClinicalTrials.gov Identifier: NCT00086333 - Completed
  Non-Small Cell Lung Carcinoma
  
• FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00530179 - Recruiting
  Diffuse Large B Cell Lymphoma
  
• Fear Conditioning Using Computer-Generated Virtual Reality
  ClinicalTrials.gov Identifier: NCT00025844 - Recruiting
  Anxiety Disorder
  
• Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00209040 - Recruiting
  PTSD
  
• Feasibility and Effectiveness of Distributing Micronutrient Sprinkles to Reduce Prevalence of Anemia
  ClinicalTrials.gov Identifier: NCT00210405 - Active, not recruiting
  Anemia
  
• Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
  ClinicalTrials.gov Identifier: NCT00284271 - Completed
  Hodgkin´s Lymphoma
  
• Feasibility and Efficacy of Delivering Blood Glucose Awareness Training Over the Internet
  ClinicalTrials.gov Identifier: NCT00327210 - Active, not recruiting
  Type 1 Diabetes Mellitus
  
• Feasibility and Outcomes of Older Patients Hospitalization
  ClinicalTrials.gov Identifier: NCT00489021 - Not yet recruiting
  Community-Acquired Pneumonia; Exacerbation of Chronic Heart Failure; Exacerbation of Chronic Obstructive Pulmonary Disease; Cellulitis
  
• Feasibility and Pilot Efficacy of Flash-Heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
  ClinicalTrials.gov Identifier: NCT00523510 - Not yet recruiting
  HIV Infections
  
• Feasibility and Practice Characteristics of FNS and Gait Robot
  ClinicalTrials.gov Identifier: NCT00508755 - Recruiting
  Stroke
  
• Feasibility and Safety of Acupuncture for Systemic Lupus
  ClinicalTrials.gov Identifier: NCT00493753 - Completed
  Systemic Lupus Erythematosus
  
• Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00464399 - Active, not recruiting
  De Novo Renal Transplantation
  
• Feasibility of a Paternered Approach to Prevent Diabetes
  ClinicalTrials.gov Identifier: NCT00302055 - Recruiting
  Pre-Diabetic State; Overweight; Obesity
  
• Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
  ClinicalTrials.gov Identifier: NCT00570037 - Recruiting
  Influenza
  
• Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H
  ClinicalTrials.gov Identifier: NCT00458250 - Recruiting
  Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, Acute
  
• Feasibility of n-of-1 Trials - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00371696 - Completed
  Osteoarthritis
  
• Feasibility of Placing Bravo PH Capsule in Proximal Esophagus
  ClinicalTrials.gov Identifier: NCT00378898 - Recruiting
  Gastroesophageal Reflux Disease
  
• Feasibility of Psychophysical Studies of Cancer Therapy Pain
  ClinicalTrials.gov Identifier: NCT00515060 - Recruiting
  Advanced Cancer; Pain
  
• Feasibility of Radiofrequency Ablation in the Management of Papillary Thyroid Cancer Under Ultra-Sound Guidance.
  ClinicalTrials.gov Identifier: NCT00381225 - Not yet recruiting
  Papillary Thyroid Cancer
  
• Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00286013 - Suspended
  Locally Advanced and Unresectable, But Non-Metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma
  
• Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)
  ClinicalTrials.gov Identifier: NCT00000621 - Active, not recruiting
  Emphysema; Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
  ClinicalTrials.gov Identifier: NCT00222027 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit
  ClinicalTrials.gov Identifier: NCT00237562 - Completed
  Cervical Intraepithelial Neoplasia
  
• Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
  ClinicalTrials.gov Identifier: NCT00178243 - Completed
  Liver Neoplasms; Neoplasm Metastasis
  
• Feasibility Study for Development of an Early Test for Ovarian Failure
  ClinicalTrials.gov Identifier: NCT00006156 - Recruiting
  Healthy; Premature Ovarian Failure
  
• Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India
  ClinicalTrials.gov Identifier: NCT00341536 - Recruiting
  Chronic Diseases
  
• Feasibility Study Into the Contraceptive Effect of Estetrol
  ClinicalTrials.gov Identifier: NCT00563472 - Recruiting
  Healthy
  
• Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00141986 - Recruiting
  Type 1 Diabetes
  
• Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa
  ClinicalTrials.gov Identifier: NCT00279500 - Active, not recruiting
  Retinitis Pigmentosa
  
• Feasibility Study of a New Fistula Pouching System
  ClinicalTrials.gov Identifier: NCT00294450 - Terminated
  Cutaneous Fistula
  
• Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)
  ClinicalTrials.gov Identifier: NCT00158470 - Completed
  HIV Infection
  
• Feasibility Study of a Percutaneous Mitral Valve Repair System.
  ClinicalTrials.gov Identifier: NCT00209339 - Active, not recruiting
  Mitral Valve Insufficiency; Mitral Valve Regurgitation; Mitral Valve Incompetence; Mitral Regurgitation; Mitral Insufficiency
  
• Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
  ClinicalTrials.gov Identifier: NCT00424567 - Completed
  Fracture, Ununited; Pseudarthrosis
  
• Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines
  ClinicalTrials.gov Identifier: NCT00514189 - Recruiting
  Leukemia
  
• Feasibility Study of CDDP + CPT-11 + PSK for ED Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00546130 - Not yet recruiting
  Small Cell Lung Cancer
  
• Feasibility Study of Collecting Multicenter Chronic GVHD Data
  ClinicalTrials.gov Identifier: NCT00506233 - Completed
  Graft-Versus-Host Disease
  
• Feasibility Study of Cone Beam Imaging for Radiation Therapy Treatment Verification
  ClinicalTrials.gov Identifier: NCT00582959 - Recruiting
  Proven Malignancy Suitable for Radiation Therapy
  
• Feasibility Study of Digital Photography and Group Discussion for People With Diabetes
  ClinicalTrials.gov Identifier: NCT00225888 - Recruiting
  Type 2 Diabetes
  
• Feasibility Study of Effective Methods for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness
  ClinicalTrials.gov Identifier: NCT00530023 - Completed
  Type 1 Diabetes
  
• Feasibility Study of Evaluating Breast Cancer Patients with Ductal Lavage
  ClinicalTrials.gov Identifier: NCT00156260 - Active, not recruiting
  Breast Cancer
  
• Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00135161 - Active, not recruiting
  neoplasms (squamous cell carcinoma of the head and neck region)
  
• Feasibility Study of Interleukin 1-Alpha with Ifosfamide, CBDCA, and Etoposide with Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
  ClinicalTrials.gov Identifier: NCT00001270 - Completed
  Breast Neoplasms; Lymphoma; Neoplasm Metastasis; Testicular Neoplasms
  
• Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00209703 - Terminated
  Colorectal Cancer
  
• Feasibility Study of Pazopanib in Combination With Chemo in Gyn Tumors
  ClinicalTrials.gov Identifier: NCT00561795 - Recruiting
  Epithelial Ovarian Cancer; Carcinoma; Uterine Disease; Tumor; Primary Peritoneal Carcinoma; Cervix Diseases
  
• Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00269152 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Feasibility Study of Photopheresis Post Angioplasty
  ClinicalTrials.gov Identifier: NCT00157001 - Active, not recruiting
  Stable Angina Pectoris; Unstable Angina Pectoris; Silent Ischemia
  
• Feasibility Study of Phototherapy System to Treat H Pylori
  ClinicalTrials.gov Identifier: NCT00306280 - Recruiting
  Helicobacter Pylori
  
• Feasibility Study of Short-Term Effects of Chiropractic Manipulation on Older Adults With Impaired Balance
  ClinicalTrials.gov Identifier: NCT00497510 - Completed
  Musculoskeletal Equilibrium
  
• Feasibility Study of Take-Home LAAM Medication - 3
  ClinicalTrials.gov Identifier: NCT00000300 - Completed
  Opioid-Related Disorders
  
• Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
  ClinicalTrials.gov Identifier: NCT00553488 - Recruiting
  Diabetes Mellitus, Type 1
  
• Feasibility Study of the NEW NORMA-SENSE
  ClinicalTrials.gov Identifier: NCT00324246 - Recruiting
  Vaginal Infection
  
• Feasibility Study Using a Remote Camera to Help Enhance Research Trial Enrollment
  ClinicalTrials.gov Identifier: NCT00390286 - Not yet recruiting
  Stroke
  
• Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions
  ClinicalTrials.gov Identifier: NCT00489164 - Terminated
  Peripheral Vascular Diseases
  
• Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00471120 - Recruiting
  Uterine Cancer; Endometrial Cancer
  
• Feasibility Study: The Effect of Prazosin for Nighttime Symptoms of Civilian PTSD
  ClinicalTrials.gov Identifier: NCT00174551 - Active, not recruiting
  Stress Disorders, Post-Traumatic
  
• Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00582205 - Recruiting
  Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Uterine Cancer
  
• Feasible Means to Address Moderately Malnourished Children Within BINP Communities
  ClinicalTrials.gov Identifier: NCT00372242 - Completed
  Mild and Moderate Malnourished Children
  
• Febuxostat versus Allopurinol Control Trial (FACT) in Subjects with Gout
  ClinicalTrials.gov Identifier: NCT00102440 - Completed
  Gout
  
• FEC Vs. FEC Plus Paclitaxel as Adjuvant Treatment of Node Positive Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00129922 - Completed
  Breast Cancer
  
• Fecal Bacterial Flora in Clostridium Difficile-Associated Diarrhea
  ClinicalTrials.gov Identifier: NCT00304876 - Recruiting
  Enterocolitis; Pseudomembranous Colitis; Antibiotic-Associated Colitis
  
• Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea
  ClinicalTrials.gov Identifier: NCT00429325 - Completed
  Acute Diarrhea
  
• Federal Study of Adherence to Medications in the Elderly (FAME)
  ClinicalTrials.gov Identifier: NCT00393419 - Completed
  Medication Adherence; Hypertension; Hyperlipidemia
  
• Feedback of Treatment Intensification Data to Reduce Cardiovascular Disease Risk (FIT)
  ClinicalTrials.gov Identifier: NCT00517686 - Not yet recruiting
  Cardiovascular Disease (CVD) Risk Factors
  
• Feeding After Neonate Surgery Review
  ClinicalTrials.gov Identifier: NCT00229866 - Terminated
  Neonatal Surgery
  
• Feeding and Wellness Among Late Preterm Infants
  ClinicalTrials.gov Identifier: NCT00470717 - Not yet recruiting
  Infant, Premature; Morbidity
  
• Feeding Bottle Design, Milk Intake and Infant Growth
  ClinicalTrials.gov Identifier: NCT00325208 - Recruiting
  Healthy Infants
  
• Feeding the Patient at Nutritional Risk: Does the Clinical Outcome Improve?
  ClinicalTrials.gov Identifier: NCT00440453 - Recruiting
  Internal Medicine Patients
  
• Feeding Tolerance in Preterm Infants
  ClinicalTrials.gov Identifier: NCT00450697 - Recruiting
  Prematurity; Feeding Intolerance
  
• Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet
  ClinicalTrials.gov Identifier: NCT00286598 - Recruiting
  Diabetes Mellitus; Peripheral Neuropathies
  
• Female Orgasmic Disorder (FOD) and Wellbutrin XL
  ClinicalTrials.gov Identifier: NCT00248209 - Recruiting
  Orgasmic Disorder
  
• Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI
  ClinicalTrials.gov Identifier: NCT00245648 - Completed
  Myocardial Infarcton
  
• Female Sexual Dysfunction: Prevalence Among Italian Healthy Women
  ClinicalTrials.gov Identifier: NCT00148200 - Recruiting
  Sexual Dysfunctions, Psychological
  
• Femoral Arterial Cannulation
  ClinicalTrials.gov Identifier: NCT00486096 - Active, not recruiting
  Congenial Disorders
  
• Femoral Vs Radial Approach and MRI Evaluation of Strokes
  ClinicalTrials.gov Identifier: NCT00329979 - Recruiting
  Aortic Stenosis
  
• Fenofibrate and Endothelial Function
  ClinicalTrials.gov Identifier: NCT00552747 - Recruiting
  Coronary Heart Disease; Hyperlipidemia
  
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO
  ClinicalTrials.gov Identifier: NCT00362323 - Recruiting
  Dyslipidemia; Glucose Metabolism Disorder
  
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
  ClinicalTrials.gov Identifier: NCT00361868 - Terminated
  Dyslipidemia; Glucose Metabolism Disorder
  
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
  ClinicalTrials.gov Identifier: NCT00362765 - Terminated
  Type II Diabetes; Dyslipidemia
  
• Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes
  ClinicalTrials.gov Identifier: NCT00349128 - Completed
  Dyslipidemia/Glucose Metabolism Disorder
  
• Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00557219 - Not yet recruiting
  Acute Renal Failure
  
• Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00103090 - Completed
  Head and Neck Cancer
  
• Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00288067 - Recruiting
  Lymphoma
  
• Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk
  ClinicalTrials.gov Identifier: NCT00017134 - Active, not recruiting
  ovarian epithelial cancer
  
• Fenretinide in Preventing Ovarian Cancer in Participants Who Are High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries
  ClinicalTrials.gov Identifier: NCT00098800 - Completed
  ovarian epithelial cancer
  
• Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00053326 - Completed
  recurrent neuroblastoma
  
• Fenretinide in Treating Children With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003191 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific; recurrent neuroblastoma
  
• Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00077402 - Active, not recruiting
  recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00080899 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Fenretinide in Treating Patients With Cervical Neoplasia
  ClinicalTrials.gov Identifier: NCT00003075 - Active, not recruiting
  Cervical Cancer; prevention of cervical cancer
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
  ClinicalTrials.gov Identifier: NCT00387504 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Fenretinide in Treating Patients With Recurrent Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00006080 - Completed
  recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; Mixed Gliomas
  
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006471 - Active, not recruiting
  Oral Cancer; Neck Cancer; Throat Cancer
  
• Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00026091 - Active, not recruiting
  stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00009971 - Completed
  limited stage small cell lung cancer; extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer
  
• Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00104923 - Recruiting
  Hodgkin's lymphoma; acute leukemia; chronic leukemia; chronic myeloproliferative disorders; Non-Hodgkin's Lymphoma; plasma cell neoplasm
  
• Fenretinide in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003250 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00295919 - Recruiting
  Brain and Central Nervous System Tumors
  
• Fenretinide to Prevent Cancer Recurrence in Treating Patients With Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00004154 - Completed
  stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder
  
• Fentanyl for Treatment Pain Caused by Radiotherapy
  ClinicalTrials.gov Identifier: NCT00523887 - Completed
  Pain
  
• Fentanyl Transdermal Matrix Patch ZR-02-01 Applied With CHADD™ (Controlled Heat-Assisted Drug Delivery) to Treat Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Chronic Pain
  ClinicalTrials.gov Identifier: NCT00278824 - Completed
  Pain
  
• Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain
  ClinicalTrials.gov Identifier: NCT00126763 - Active, not recruiting
  Pain
  
• Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain
  ClinicalTrials.gov Identifier: NCT00108771 - Completed
  Pain
  
• Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
  ClinicalTrials.gov Identifier: NCT00126789 - Active, not recruiting
  Pain; Cancer
  
• Fentanyl Ultra Low Doses Effects on the Nociceptive Threshold
  ClinicalTrials.gov Identifier: NCT00454259 - Not yet recruiting
  Pain, Postoperative
  
• Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery
  ClinicalTrials.gov Identifier: NCT00538499 - Recruiting
  Pain; Perioperative/Postoperative Complications
  
• Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF)
  ClinicalTrials.gov Identifier: NCT00520780 - Recruiting
  Chronic Heart Failure; Iron Deficiency; Iron Deficiency Anemia; Anaemia
  
• Fertility Preservation by Ovarian and Oocyte Cryopreservation
  ClinicalTrials.gov Identifier: NCT00578500 - Recruiting
  Female Patients Aged 5-35 Prior to Systemic Chemotherapy; With Significant Risk of Ovarian Toxicity
  
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients
  ClinicalTrials.gov Identifier: NCT00233597 - Completed
  Anemia
  
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
  ClinicalTrials.gov Identifier: NCT00255424 - Completed
  Anemia
  
• Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
  ClinicalTrials.gov Identifier: NCT00255437 - Completed
  Anemia
  
• FES Assisted Walking: Enhancement of Walking Function After Stroke
  ClinicalTrials.gov Identifier: NCT00552916 - Recruiting
  Stroke
  
• FES Cycling for Children With SCI
  ClinicalTrials.gov Identifier: NCT00245726 - Active, not recruiting
  Spinal Cord Injury
  
• Fesoterodine "Add-on" Male Overactive Bladder Study
  ClinicalTrials.gov Identifier: NCT00546637 - Recruiting
  Overactive Bladder Syndrome
  
• FESOTERODINE FLEXIBLE DOSE STUDY
  ClinicalTrials.gov Identifier: NCT00536484 - Recruiting
  Overactive Bladder
  
• Fetal Alcohol Syndrome/ARND Research Consortion
  ClinicalTrials.gov Identifier: NCT00164554 - Completed
  Treatment; Control
  
• Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
  ClinicalTrials.gov Identifier: NCT00164229 - Completed
  Treatment; Control
  
• Fetal Anatomy by Three-Dimensional Ultrasound
  ClinicalTrials.gov Identifier: NCT00340002 - Recruiting
  Congenital Anomalies; Imaging; Prenatal Care
  
• Fetal Aortic Pulsewave Velocity: A Novel Doppler Ultrasound Method of Measuring the Biophysical Properties of the Fetal Aorta
  ClinicalTrials.gov Identifier: NCT00359034 - Recruiting
  Healthy
  
• Fetal Growth Evaluation by Three-Dimensional Ultrasound
  ClinicalTrials.gov Identifier: NCT00340171 - Recruiting
  Fetal Growth Abnormalities
  
• Fetal Growth Restriction & Maternal Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00241683 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Fetal Immunity to Falciparum Malaria
  ClinicalTrials.gov Identifier: NCT00314899 - Recruiting
  Plasmodium Falciparum Malaria
  
• Fetal Loss in Women with Unprovoked Thromboembolism (FLUTE)
  ClinicalTrials.gov Identifier: NCT00149357 - Recruiting
  Venous Thromboembolism; fetal loss
  
• Fetal Neurobehavior in Non-Methadone Maintained Women in Substance Abuse Treatment
  ClinicalTrials.gov Identifier: NCT00522626 - Recruiting
  Drug Exposed Fetus
  
• Fetal Pulse Oximetry Trial (FOX)
  ClinicalTrials.gov Identifier: NCT00098709 - Terminated
  Pregnancy
  
• Fetal, Infant, & Early Childhood Antecedents of Cancer in Women: Maternal Cohort Study of the Nurses' Health Studies
  ClinicalTrials.gov Identifier: NCT00340145 - Recruiting
  Cancer
  
• Fetoscopic Selective Laser Photocoagulation in Twin-Twin Transfusion Syndrome
  ClinicalTrials.gov Identifier: NCT00345852 - Active, not recruiting
  Twin to Twin Transfusion Syndrome
  
• Fetoscopic Tracheal Balloon Occlusion in Unborns With Severe Congenital Diaphragmatic Hernia - EUROTRIAL I
  ClinicalTrials.gov Identifier: NCT00373763 - Recruiting
  Diaphragmatic Hernia
  
• Fetoscopic Tracheal Balloon Occlusion in Unborns With Severe Congenital Diaphragmatic Hernia - EUROTRIAL II
  ClinicalTrials.gov Identifier: NCT00373438 - Not yet recruiting
  Diaphragmatic Hernia
  
• Fexofenadine in Pruritic Skin Disease
  ClinicalTrials.gov Identifier: NCT00261079 - Completed
  Pruritus
  
• FFA Metabolism in Different Types of Human Obesity
  ClinicalTrials.gov Identifier: NCT00068900 - Recruiting
  Obesity
  
• fFN & E3 in the Prediction of PTB in Women with Twin Pregnancies Receiving 17OHP or Placebo
  ClinicalTrials.gov Identifier: NCT00156000 - Terminated
  Preterm Delivery; Preterm Birth
  
• FFS - Far Field Sensing Test Study in Cardiac Dual Chamber Pacemakers
  ClinicalTrials.gov Identifier: NCT00196144 - Completed
  Atrial Fibrillation
  
• FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
  ClinicalTrials.gov Identifier: NCT00424866 - Not yet recruiting
  Peripheral Arterial Disease; Stenosis; Critical Leg Ischemia; Intermittent Claudication
  
• FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
  ClinicalTrials.gov Identifier: NCT00425178 - Completed
  Chronic Wounds; Diabetes; Venous Stasis Ulcers
  
• FHA: Metabolism and Stress Reactivity
  ClinicalTrials.gov Identifier: NCT00453219 - Not yet recruiting
  Anovulation; FHA; Eumenorrhea
  
• Fibre and Appetite Regulation Trial (FART)
  ClinicalTrials.gov Identifier: NCT00247455 - Completed
  Obesity; Diabetes
  
• Fibrin Melanoma Axillary Node Study in Patients With Melanoma
  ClinicalTrials.gov Identifier: NCT00504582 - Recruiting
  Melanoma
  
• Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
  ClinicalTrials.gov Identifier: NCT00028951 - Active, not recruiting
  Lymphedema; perioperative/postoperative complications; stage I vulvar cancer; stage II vulvar cancer; stage III vulvar cancer; stage IV vulvar cancer
  
• Fibrin Sealant Vascular Surgery Study
  ClinicalTrials.gov Identifier: NCT00576420 - Recruiting
  Adjunct to Hemostasis in Vascular Surgery (Synthetic Vascular Grafts)
  
• Fibroid Growth Study
  ClinicalTrials.gov Identifier: NCT00340288 - Active, not recruiting
  Uterine Leiomyomas
  
• Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
  ClinicalTrials.gov Identifier: NCT00229346 - Completed
  Premenstrual Syndrome
  
• Fibromyalgia in Men Suffering From PTSD
  ClinicalTrials.gov Identifier: NCT00229294 - Completed
  Fibromyalgia; Posttraumatic Stress Disorder; Major Depressive Disorder
  
• Fibromyalgia Study In Adults
  ClinicalTrials.gov Identifier: NCT00256893 - Completed
  Fibromyalgia; Pain
  
• Fibromyalgia: A Randomized Controlled Trial of a Mind/Body Intervention
  ClinicalTrials.gov Identifier: NCT00010777 - Completed
  Fibromyalgia
  
• FibroScan in Patients with Hepatitis B and C Presenting for Liver Biopsy
  ClinicalTrials.gov Identifier: NCT00125762 - Recruiting
  Cirrhosis; Hepatitis B; Hepatitis C
  
• Fibrosis in Renal Allografts
  ClinicalTrials.gov Identifier: NCT00493194 - Recruiting
  Kidney Failure, Chronic; Transplantation; Immunosuppression; Interstitial Fibrosis
  
• Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial
  ClinicalTrials.gov Identifier: NCT00059332 - Recruiting
  Cerebrovascular Accident
  
• Field Evaluation of Plant-based Mosquito Control
  ClinicalTrials.gov Identifier: NCT00116766 - Completed
  Malaria; Arbovirus Infections
  
• Fifteen Year Follow-up of 5,500 Black and 5,500 Other Hypertensives
  ClinicalTrials.gov Identifier: NCT00005417 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Kidney Failure, Chronic
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• Filgrastim Compared With Filgrastim-SD/01 Following Combination Chemotherapy in Treating Patients With Newly Diagnosed Sarcoma
  ClinicalTrials.gov Identifier: NCT00020137 - Active, not recruiting
  Cardiac Toxicity; Neutropenia; Sarcoma
  
• Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon alfa in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00005987 - Completed
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00030758 - Active, not recruiting
  Neutropenia; stage I breast cancer; stage II breast cancer
  
• Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002836 - Active, not recruiting
  recurrent breast cancer
  
• Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors
  ClinicalTrials.gov Identifier: NCT00511550 - Recruiting
  Healthy
  
• Filgrastim-Mobilized Peripheral Stem Cell Transplantation Compared With Bone Marrow Transplantation From Unrelated Donors in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00075816 - Recruiting
  acute leukemia; chronic leukemia; chronic myeloproliferative disorders; myelodysplastic and myeloproliferative disease
  
• Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
  ClinicalTrials.gov Identifier: NCT00005930 - Recruiting
  Hematopoietic Stem Cell Mobilization
  
• Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00025545 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ...
  
• Filtered Trial for Amlodipine Non-Responder
  ClinicalTrials.gov Identifier: NCT00558064 - Recruiting
  Hypertension
  
• Filtered Trial for Telmisartan 40mg Non-Responder
  ClinicalTrials.gov Identifier: NCT00550953 - Recruiting
  Hypertension
  
• FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent
  ClinicalTrials.gov Identifier: NCT00233792 - Completed
  Coronary Artery Disease
  
• FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent
  ClinicalTrials.gov Identifier: NCT00233818 - Completed
  Coronary Artery Disease
  
• Financial and Clinical Impact of Repeal of the Pennsylvania Motorcycle Helmet Law
  ClinicalTrials.gov Identifier: NCT00200135 - Recruiting
  Craniocerebral Trauma; Facial Injuries
  
• Financial Incentives for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00128375 - Completed
  Smoking
  
• Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00302718 - Recruiting
  Hypertension
  
• Finasteride in Treating Patients Undergoing Surgery for Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00438464 - Recruiting
  Prostate Cancer
  
• FINDER I - A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg
  ClinicalTrials.gov Identifier: NCT00305448 - Active, not recruiting
  Advanced Breast Cancer; Metastatic Breast Cancer
  
• FINDER II - A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
  ClinicalTrials.gov Identifier: NCT00313170 - Recruiting
  Advanced Breast Cancer; Metastatic Breast Cancer
  
• Finding Diabetes Mellitus Among Veterans
  ClinicalTrials.gov Identifier: NCT00007696 - Completed
  Diabetes Mellitus
  
• Finding of Optimal Dose for NT 201, a Botulinum Toxin Type A Preparation Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
  ClinicalTrials.gov Identifier: NCT00430586 - Active, not recruiting
  Glabellar Frown Lines
  
• Fine Mapping of COPD Susceptibility Genes
  ClinicalTrials.gov Identifier: NCT00106444 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease; Lung Diseases, Obstructive
  
• FINNPROSTATE Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00293670 - Active, not recruiting
  Patients With T1-4 Advanced Prostate Cancer
  
• Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
  ClinicalTrials.gov Identifier: NCT00548769 - Recruiting
  Multiple Sclerosis
  
• FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial Disease
  ClinicalTrials.gov Identifier: NCT00274157 - Recruiting
  Peripheral Vascular Disease
  
• FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy
  ClinicalTrials.gov Identifier: NCT00125723 - Active, not recruiting
  Neutropenia
  
• First Breath: Neonatal Resuscitation in Developing Countries
  ClinicalTrials.gov Identifier: NCT00136708 - Recruiting
  Asphyxia
  
• First Episode Schizophrenia and Cannabis-Related Disorder Study
  ClinicalTrials.gov Identifier: NCT00573287 - Recruiting
  Cannabis-Related Disorder; Substance-Related Disorders; Schizophrenia; Psychotic Disorders
  
• First Experimental Study of Transference-Interpretations (FEST)
  ClinicalTrials.gov Identifier: NCT00423462 - Completed
  Mood Disorders; Anxiety Disorders; Personality Disorders
  
• First Line Chemotherapy Treatment of Advanced NSCLC
  ClinicalTrials.gov Identifier: NCT00308750 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia
  ClinicalTrials.gov Identifier: NCT00322452 - Active, not recruiting
  Non-Small Cell Lung Cancer
  
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
  ClinicalTrials.gov Identifier: NCT00384176 - Recruiting
  Colorectal Cancer
  
• First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)
  ClinicalTrials.gov Identifier: NCT00392054 - Recruiting
  Atrial Fibrillation
  
• First Line Therapy for Patients With Metastaic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00456846 - Not yet recruiting
  Metastatic Breast Cancer
  
• First Safety Study in Humans of a Single Dose of CPG 52364
  ClinicalTrials.gov Identifier: NCT00547014 - Recruiting
  Healthy Volunteers
  
• First Step With Singulair® Therapy
  ClinicalTrials.gov Identifier: NCT00545324 - Completed
  Asthma
  
• First Study of the Safety of CNTO 888 in Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00537368 - Recruiting
  Cancer
  
• First Time in Human Study With GSK1018921
  ClinicalTrials.gov Identifier: NCT00527020 - Recruiting
  Schizophrenia
  
• First Time in Man Study of Finafloxacin Hydrochloride
  ClinicalTrials.gov Identifier: NCT00483158 - Recruiting
  Helicobacter Infections; Urinary Tract Infection
  
• First Time in Man Trial for Friulimicin B
  ClinicalTrials.gov Identifier: NCT00492271 - Recruiting
  Community Acquired Pneumonia; Staphylococcal Skin Infections
  
• First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
  ClinicalTrials.gov Identifier: NCT00537901 - Active, not recruiting
  Colonic Neoplasms; Rectal Neoplasms
  
• First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients
  ClinicalTrials.gov Identifier: NCT00251186 - Terminated
  Colorectal Cancer
  
• First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu
  ClinicalTrials.gov Identifier: NCT00520975 - Recruiting
  Breast Cancer
  
• First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
  ClinicalTrials.gov Identifier: NCT00339586 - Recruiting
  Lung Neoplasms; Non-Small Cell Lung Cancer; Adenocarcinoma, Bronchiolo-Alveolar
  
• First-Line Gefitinib vs.Chemotherapy for Lung Adenocarcinoma in Never Smoker
  ClinicalTrials.gov Identifier: NCT00455936 - Recruiting
  Lung Cancer
  
• First-Line Treatment for Adenocarcinoma Patients With EGFR Mutation
  ClinicalTrials.gov Identifier: NCT00344773 - Active, not recruiting
  Pulmonary Cancer
  
• First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00456261 - Recruiting
  Lung Cancer
  
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
  ClinicalTrials.gov Identifier: NCT00389155 - Active, not recruiting
  Bladder Cancer; Transitional Cell Carcinoma; Metastasis
  
• First-line treatment of metastatic colorectal cancer with oxaliplatin/5-FU/leucovorin plus PTK787/ZK 222584 or placebo
  ClinicalTrials.gov Identifier: NCT00056459 - Active, not recruiting
  Colorectal Neoplasms; Colonic Neoplasms; Rectal Neoplasms
  
• First-Line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin
  ClinicalTrials.gov Identifier: NCT00316186 - Recruiting
  Small Cell Lung Cancer
  
• FirstWIND: Weight Loss Interventions After Delivery
  ClinicalTrials.gov Identifier: NCT00377026 - Recruiting
  Pre-Pregancy Overweight; Pre-Pregnancy Obesity
  
• Fish Oil (Omega 3), Immune Function, and Mood
  ClinicalTrials.gov Identifier: NCT00385723 - Recruiting
  Inflammation
  
• Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00090402 - Completed
  Alzheimer's Disease; Oxidative Stress; Dementia; Hyperlipidemia; Inflammation
  
• Fish Oil and Asthma in House Dust Mite Allergy
  ClinicalTrials.gov Identifier: NCT00380926 - Completed
  Allergic Asthma; Bronchial Inflammation; House Dust Mite Allergy
  
• Fish Oil and Biomarkers of Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00527436 - Not yet recruiting
  Cardiovascualr Risk Factors
  
• Fish Oil for the Treatment of Depression in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00122954 - Recruiting
  Multiple Sclerosis; Depression
  
• Fish Oil in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia or Who Are at Risk for Developing Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00253643 - Recruiting
  Precancerous/Nonmalignant Condition; Prostate Cancer
  
• Fish Oil Supplementation in Lactation
  ClinicalTrials.gov Identifier: NCT00266305 - Completed
  Development and Health
  
• FishGastro Study
  ClinicalTrials.gov Identifier: NCT00145015 - Recruiting
  Colorectal Cancer; Ulcerative Colitis; Polyps
  
• Fitness and Daily Function in Adults
  ClinicalTrials.gov Identifier: NCT00018265 - Completed
  Cardiovascular Disease
  
• Fitness and Exercise for People With Arthritis
  ClinicalTrials.gov Identifier: NCT00252070 - Completed
  Arthritis
  
• Fitness Training After Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00251108 - Completed
  Craniocerebral Trauma
  
• Fitness Training in Children
  ClinicalTrials.gov Identifier: NCT00205296 - Active, not recruiting
  Obesity; Low Fitness
  
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00000940 - Active, not recruiting
  HIV Infections
  
• Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis
  ClinicalTrials.gov Identifier: NCT00323960 - Recruiting
  Juvenile Dermatomyositis
  
• Five-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 to Less Than 12 Months of Age with Mild to Moderate Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00120523 - Active, not recruiting
  Atopic Dermatitis
  
• Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples
  ClinicalTrials.gov Identifier: NCT00363558 - Completed
  Grafting, Skin; Burn
  
• Fixation Stability and Bony Healing Following Open Wedge High Tibial Osteotomy
  ClinicalTrials.gov Identifier: NCT00284596 - Recruiting
  Opening Wedge High Tibial Osteotomy
  
• Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
  ClinicalTrials.gov Identifier: NCT00384436 - Active, not recruiting
  Major Depressive Disorder
  
• Fixed Dose Heparin Study
  ClinicalTrials.gov Identifier: NCT00182403 - Completed
  Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism
  
• Fixed Dose MMF Vs Concentration Controlled MMF After Renal Transplantation
  ClinicalTrials.gov Identifier: NCT00166244 - Active, not recruiting
  De Novo Renal Transplant Recipient.
  
• Fixed Dose NESP Study in Subjects With CRI
  ClinicalTrials.gov Identifier: NCT00526929 - Completed
  Pre-Dialysis
  
• FK506 Phase 3 Study: a Study for Steroid Non-Resistant Myasthenia Gravis (MG) Patients
  ClinicalTrials.gov Identifier: NCT00309088 - Active, not recruiting
  Myasthenia Gravis
  
• FK506 Phase 3 Study: an Open Study for Steroid Resistant, Non-Thymectomized MG Patients
  ClinicalTrials.gov Identifier: NCT00309101 - Recruiting
  Myasthenia Gravis
  
• FK506 Phase 4 Study: A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
  ClinicalTrials.gov Identifier: NCT00319917 - Recruiting
  Rheumatoid Arthritis
  
• FL-2000 Study for Newly Diagnosed Follicular Lymphoma Patients with a Large Tumor Burden
  ClinicalTrials.gov Identifier: NCT00136552 - Completed
  Lymphoma
  
• FLAG+Ida With G-CSF Priming for Patients Younger Than 60 Years With Resistant AML
  ClinicalTrials.gov Identifier: NCT00559221 - Recruiting
  Acute Myeloid Leukemia
  
• FLAME: Airway Inflammation Monitoring in Asthma and Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00404859 - Completed
  Asthma; Cystic Fibrosis
  
• FLASH Study: A study of roflumilast versus placebo in patients with asthma
  ClinicalTrials.gov Identifier: NCT00076076 - Completed
  Asthma
  
• FLAT Study. First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00137540 - Terminated
  Atrial Fibrillation
  
• Flavocoxid, A Plant-Derived Therapy, for the Treatment of Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00294125 - Active, not recruiting
  Osteoarthritis
  
• Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile
  ClinicalTrials.gov Identifier: NCT00559663 - Completed
  Healthy
  
• Flavonoid Supplementation and Endothelial Function
  ClinicalTrials.gov Identifier: NCT00331227 - Completed
  Healthy
  
• Flavonoids and Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00006504 - Completed
  Cardiovascular Diseases; Heart Diseases; Cerebrovascular Accident; Myocardial Infarction; Coronary Disease
  
• Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00016185 - Completed
  unspecified adult solid tumor, protocol specific
  
• Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00064285 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia
  
• Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00006485 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel
  ClinicalTrials.gov Identifier: NCT00006245 - Completed
  stage III esophageal cancer; stage IV esophageal cancer; recurrent esophageal cancer; squamous cell carcinoma of the esophagus; ...
  
• Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
  ClinicalTrials.gov Identifier: NCT00278330 - Suspended
  Leukemia; Myelodysplastic Syndromes
  
• Flavopiridol for Treating Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00005670 - Completed
  Head and Neck Cancer; Head and Neck Neoplasm; Squamous Cell Carcinoma
  
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00012181 - Active, not recruiting
  childhood bone cancer; childhood brain cancer; childhood eye cancer; childhood kidney tumors; childhood non-Hodgkin's lymphoma; ...
  
• Flavopiridol in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00377104 - Recruiting
  Leukemia; Lymphoma
  
• Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003620 - Completed
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; refractory chronic lymphocytic leukemia; ...
  
• Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098371 - Recruiting
  B-cell Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• Flavopiridol in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00112684 - Recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; Pheochromocytoma; Thyroid Cancer
  
• Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00005971 - Active, not recruiting
  Stage IV Melanoma
  
• Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cance
  ClinicalTrials.gov Identifier: NCT00070239 - Suspended
  Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer
  
• Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00058240 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia; Waldenstrom's Macroglobulinemia; recurrent small lymphocytic lymphoma
  
• Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00005074 - Active, not recruiting
  stage I mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma; ...
  
• Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003039 - Completed
  recurrent adult lymphoblastic lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00020189 - Completed
  Head and Neck Cancer; Thromboembolism
  
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00023894 - Completed
  recurrent endometrial cancer
  
• Flavopiridol in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003256 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate
  
• Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00005974 - Active, not recruiting
  stage IVB adult soft tissue sarcoma; stage IVA adult soft tissue sarcoma; stage III adult soft tissue sarcoma
  
• Flavopiridol in Treating Patients With Refractory Cancer
  ClinicalTrials.gov Identifier: NCT00019344 - Completed
  Leukemia; Lymphoma; Prostate Cancer; Eye Cancer
  
• Flavopiridol in Treating Patients With Refractory or Recurrent Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00445341 - Recruiting
  Lymphoma
  
• Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00101231 - Recruiting
  adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00112723 - Recruiting
  Leukemia; Lymphoma; plasma cell neoplasm
  
• Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00047203 - Completed
  refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00016939 - Completed
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003690 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IV prostate cancer; recurrent prostate cancer; Stage IV Melanoma; Recurrent Melanoma; ...
  
• Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00047307 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00016016 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00407966 - Recruiting
  Leukemia
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00470197 - Recruiting
  Leukemia
  
• Flavopiridol, Fludarabine, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00058227 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Hairy Cell Leukemia
  
• Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00079352 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Flavopiridol, Oxaliplatin, Fluorouracil, and Leucovorin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00080990 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Flaxseed for the Treatment of Hot Flashes
  ClinicalTrials.gov Identifier: NCT00275704 - Completed
  Hot Flashes
  
• Flecainide in Treating Patients With Chronic Neuropathic Pain
  ClinicalTrials.gov Identifier: NCT00002996 - Active, not recruiting
  Pain
  
• Flecainide-Short Long Study (Flec-SL)
  ClinicalTrials.gov Identifier: NCT00215774 - Recruiting
  Atrial Fibrillation
  
• FLEX - Long-Term Extension of FIT (Fracture Intervention Trial)
  ClinicalTrials.gov Identifier: NCT00398931 - Completed
  Osteoporosis, Postmenopausal
  
• Flexibility: A Study to Assess the Impact of Once Per Cycle Correction and Maintenance Dosing of Darbepoetin Alfa in Subjects with Non-Myeloid Malignancies with Anemia Due to Chemotherapy
  ClinicalTrials.gov Identifier: NCT00144131 - Completed
  Non-Myeloid Malignancies; Anemia; Chemotherapy
  
• Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.
  ClinicalTrials.gov Identifier: NCT00392418 - Completed
  Anemia
  
• Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
  ClinicalTrials.gov Identifier: NCT00417066 - Completed
  Infertility; Premature Ovarian Failure
  
• Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00440284 - Active, not recruiting
  Type 2 Diabetes
  
• Flexitouch Compression System for Venous Stasis Ulcer
  ClinicalTrials.gov Identifier: NCT00534937 - Recruiting
  Venous Stasis Ulcer
  
• Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00577317 - Not yet recruiting
  Cervical Cancer; Endometrial Cancer; Lymphedema; Vulvar Cancer
  
• Flibanserin Randomized Withdrawal Trial in Pre-Menopausal Women
  ClinicalTrials.gov Identifier: NCT00277914 - Active, not recruiting
  Sexual Dysfunctions, Psychological
  
• Flibanserin Versus Placebo in Premenopaused Women With HSDD
  ClinicalTrials.gov Identifier: NCT00491829 - Recruiting
  Sexual Dysfunctions, Psychological
  
• FloSeal Tubeless Exit Versus Cope Loop Nephrostomy Versus Fascial Stitch Following Percutaneous Nephrolithotripsy
  ClinicalTrials.gov Identifier: NCT00360477 - Completed
  Kidney Calculi
  
• Flossing With Chlorhexidine
  ClinicalTrials.gov Identifier: NCT00471783 - Completed
  Gingivitis
  
• FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
  ClinicalTrials.gov Identifier: NCT00370097 - Active, not recruiting
  Asthma
  
• FLOW-Finding Lasting Options for Women
  ClinicalTrials.gov Identifier: NCT00397202 - Recruiting
  Menstruation
  
• FLOX in Combination with Cetuximab in First-Line Treatment of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00145314 - Recruiting
  Metastatic Colorectal Cancer
  
• Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00410956 - Recruiting
  Liver Cancer
  
• Floxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003753 - Completed
  Colon Cancer; liver metastases; Rectal Cancer
  
• Flt3L and CD40L to Treat Metastatic Melanoma and Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00012532 - Completed
  Melanoma; Renal Cancer
  
• flt3L in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006223 - Completed
  Acute Myeloid Leukemia
  
• Flt3L in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003431 - Completed
  liver metastases; lung metastases; stage IV colon cancer
  
• flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00019396 - Completed
  Stage IV Melanoma; Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer; Recurrent Melanoma
  
• FLU-VACS
  ClinicalTrials.gov Identifier: NCT00133523 - Active, not recruiting
  Influenza
  
• Fluconazole Compared With Voriconazole in Preventing Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Transplantation
  ClinicalTrials.gov Identifier: NCT00075803 - Active, not recruiting
  childhood non-Hodgkin's lymphoma; Infection; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002533 - Completed
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Fluconazole Pharmacokinetics in Infants
  ClinicalTrials.gov Identifier: NCT00514358 - Active, not recruiting
  Fungal Infection
  
• Fluconazole Prophylaxis of Thrush in AIDS
  ClinicalTrials.gov Identifier: NCT00001542 - Completed
  Acquired Immunodeficiency Syndrome; Candidiasis; Oral Candidiasis
  
• Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
  ClinicalTrials.gov Identifier: NCT00304772 - Recruiting
  Candidiasis; Sepsis
  
• Fludara plus Alemtuzumab (Campath, MabCampath) vs Fludara alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) patients
  ClinicalTrials.gov Identifier: NCT00086580 - Recruiting
  B-Cell Lymphocytic Leukemia
  
• Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00382694 - Active, not recruiting
  Multiple Myeloma
  
• Fludarabine and 400 CGY Total Body Irradiation for Recipients of HLA-Matched or Mis-Matched Family or Unrelated Donor Hematopoietic Stem Cell Transplants Who Have Rejected Their First Allogeneic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00472329 - Recruiting
  Graft Failure
  
• Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00462332 - Recruiting
  Leukemia
  
• Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
  ClinicalTrials.gov Identifier: NCT00070135 - Recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
  ClinicalTrials.gov Identifier: NCT00346359 - Suspended
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00389506 - Recruiting
  Lymphoma
  
• Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00006252 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia
  
• Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00281983 - Active, not recruiting
  Leukemia; Lymphoma
  
• Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00024440 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00281918 - Active, not recruiting
  Leukemia
  
• Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
  ClinicalTrials.gov Identifier: NCT00529880 - Recruiting
  Acute Myeloid Leukemia
  
• Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00281892 - Recruiting
  Anemia; Leukemia
  
• Fludarabine and Low-Dose Total-Body Irradiation Followed By Donor Stem Cell Transplantation and Mycophenolate Mofetil and Cyclosporine in Treating Patients With Fanconi's Anemia
  ClinicalTrials.gov Identifier: NCT00093743 - Recruiting
  Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes
  
• Fludarabine and Melphalan Followed by Tacrolimus and Methotrexate in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00121186 - Active, not recruiting
  adult Hodgkin''s lymphoma; adult non-Hodgkin''s lymphoma
  
• Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003248 - Active, not recruiting
  stage II chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia; stage IV chronic lymphocytic leukemia; ...
  
• Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Did Not Respond to Fludarabine
  ClinicalTrials.gov Identifier: NCT00104858 - Recruiting
  refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma; B-cell Chronic Lymphocytic Leukemia; ...
  
• Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00110058 - Completed
  accelerated phase chronic myelogenous leukemia; childhood chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; ...
  
• Fludarabine and Rituximab Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00098670 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00117156 - Active, not recruiting
  Lymphoma, Non-Hodgkin; MALT Lymphoma
  
• Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00551239 - Recruiting
  Leukemia; Lymphoma
  
• Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00096018 - Recruiting
  stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
  
• Fludarabine and Total-Body Irradiation Followed By a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00397813 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis
  
• Fludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer Who are Undergoing a Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00112593 - Recruiting
  adult solid tumor; childhood solid tumor; hematopoietic and lymphoid cancer
  
• Fludarabine and Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Peripheral Stem Cell Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00268268 - Recruiting
  Chronic Myeloproliferative Disorders; Diamond-Blackfan Anemia; Fanconi Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition
  
• Fludarabine and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00119340 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00036738 - Recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00243009 - Active, not recruiting
  Kidney Cancer
  
• Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Progressive Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00242931 - Recruiting
  Prostate Cancer
  
• Fludarabine and White Blood Cell Infusion Followed By Vaccine Therapy and GM-CSF in Treating Patients With Advanced Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00458965 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00086775 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00317759 - Active, not recruiting
  Melanoma (Skin)
  
• Fludarabine Followed by Campath-1H in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00004857 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; ...
  
• Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00091143 - Recruiting
  Recurrent Melanoma; stage III melanoma; Stage IV Melanoma
  
• Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00049075 - Active, not recruiting
  B-cell Chronic Lymphocytic Leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
  ClinicalTrials.gov Identifier: NCT00004194 - Active, not recruiting
  Graft Versus Host Disease
  
• Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00262795 - Active, not recruiting
  Leukemia
  
• Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00262782 - Active, not recruiting
  Leukemia
  
• Fludarabine Plus Cyclophosphamide Followed by Zevalin in Non-Follicular Indolent Lymphomas Refractory or Relapsed
  ClinicalTrials.gov Identifier: NCT00354822 - Recruiting
  Lymphoma, Non-Hodgkin
  
• Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002779 - Active, not recruiting
  Lymphoma; Lymphoma, Small Lymphocytic; Lymphoma, Mantle-Cell; Waldenstrom's Macroglobulinemia; Lymphoma, Mucosa-Associated Lymphoid Tissue
  
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00276848 - Active, not recruiting
  Leukemia
  
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003764 - Active, not recruiting
  stage 0 chronic lymphocytic leukemia; stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; ...
  
• Fludarabine, Alemtuzumab, and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Donor White Blood Cell Infusion in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00416884 - Active, not recruiting
  Leukemia
  
• Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
  ClinicalTrials.gov Identifier: NCT00448357 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed or Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005593 - Active, not recruiting
  Leukemia
  
• Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00073879 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003659 - Active, not recruiting
  stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia
  
• Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00281931 - Active, not recruiting
  Leukemia
  
• Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00564512 - Not yet recruiting
  Leukemia
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By an Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00305682 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00255684 - Recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Immunodeficiency or Noncancerous Inherited Disorders
  ClinicalTrials.gov Identifier: NCT00358657 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia
  ClinicalTrials.gov Identifier: NCT00489281 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin, and Umbilical Cord Blood Transplant in Treating Patients With Refractory Hematologic Cancers or Other Diseases
  ClinicalTrials.gov Identifier: NCT00354172 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Umbilical Cord Blood Stem Cell Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer and Other Diseases
  ClinicalTrials.gov Identifier: NCT00343798 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00134004 - Recruiting
  childhood Hodgkin''s lymphoma; childhood non-Hodgkin''s lymphoma; chronic myeloproliferative disorders; Leukemia; Lymphoma; plasma cell neoplasm
  
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00309842 - Recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
  
• Fludarabine, Cyclophosphamide, and Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00509496 - Recruiting
  Melanoma (Skin)
  
• Fludarabine, Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00335608 - Recruiting
  Precancerous/Nonmalignant Condition
  
• Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00488709 - Completed
  Acute Myeloid Leukemia
  
• Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00169208 - Completed
  Follicular Lymphoma
  
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00577993 - Active, not recruiting
  Lymphoma
  
• Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
  ClinicalTrials.gov Identifier: NCT00577161 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Fludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  ClinicalTrials.gov Identifier: NCT00143065 - Active, not recruiting
  Lymphoma, Small Lymphocytic; Lymphocytic Leukemia, Chronic
  
• Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With CLL
  ClinicalTrials.gov Identifier: NCT00536341 - Not yet recruiting
  Chronic Lymphocytic Leukemia
  
• Fludarabine, Total-body Irradiation, Donor Peripheral Stem Cell Transplantation, and Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00005799 - Active, not recruiting
  Leukemia; Renal Cell Cancer; Lymphoma; Eye Cancer; Kidney Cancer
  
• Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00474747 - Recruiting
  Aplastic Anemia
  
• Fludarabine-Based Conditioning for Severe Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00326417 - Recruiting
  Anemia, Aplastic
  
• Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
  ClinicalTrials.gov Identifier: NCT00550628 - Recruiting
  Colorectal Cancer; Neoplasm of Uncertain Malignant Potential
  
• Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00416455 - Recruiting
  Cervical Cancer
  
• Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00433433 - Recruiting
  Lymphoma
  
• Fludeoxyglucose F 18 PET/CT Scans in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00424138 - Recruiting
  Lung Cancer
  
• Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
  ClinicalTrials.gov Identifier: NCT00060008 - Recruiting
  neurofibromatosis 1 and 2 (NF1 and NF2)
  
• Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00238368 - Recruiting
  Lymphoma
  
• Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00499395 - Completed
  Colorectal Cancer; Metastatic Cancer
  
• Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00083083 - Recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis
  ClinicalTrials.gov Identifier: NCT00318435 - Active, not recruiting
  Stenosis
  
• Fluid Infusion During Breast Surgery.
  ClinicalTrials.gov Identifier: NCT00431743 - Not yet recruiting
  Varicose Veins
  
• Fluid Management for Cesarean Section
  ClinicalTrials.gov Identifier: NCT00488111 - Recruiting
  Cesarean Section
  
• Fluid Retention in AVANDIA Treated Subjects With Autonomic Neuropathy
  ClinicalTrials.gov Identifier: NCT00422955 - Completed
  Type 2 Diabetes
  
• Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation
  ClinicalTrials.gov Identifier: NCT00326729 - Recruiting
  Burns
  
• Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest
  ClinicalTrials.gov Identifier: NCT00347477 - Recruiting
  Cardiac Arrest
  
• Fluids and Catheters Treatment Trial (FACTT) - ARDS Clinical Research Network
  ClinicalTrials.gov Identifier: NCT00281268 - Active, not recruiting
  Acute Respiratory Distress Syndrome; Lung Diseases
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Fluocinolone Implant to Treat Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00008515 - Completed
  Choroidal Neovascularization; Macular Degeneration
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
  ClinicalTrials.gov Identifier: NCT00084903 - Recruiting
  Cervical Cancer
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients
  ClinicalTrials.gov Identifier: NCT00512642 - Active, not recruiting
  Lung Cancer
  
• Fluorescence-Guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid
  ClinicalTrials.gov Identifier: NCT00241670 - Completed
  Brain Cancer; Brain Tumors; Cancer of Brain; Primary Brain Tumors; Brain Tumor, Primary
  
• Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00019201 - Completed
  Head and Neck Cancer; Lung Cancer
  
• Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-Aboriginal Children
  ClinicalTrials.gov Identifier: NCT00435500 - Active, not recruiting
  Dental Caries
  
• Fluoride Varnish Study
  ClinicalTrials.gov Identifier: NCT00066963 - Active, not recruiting
  Dental Caries
  
• Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00444223 - Recruiting
  Lung Cancer
  
• Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00464282 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
  ClinicalTrials.gov Identifier: NCT00068146 - Recruiting
  Lymphoproliferative Disorders; Lymphoma
  
• Fluorophotometry Evaluation of Lubricant Eye Drops
  ClinicalTrials.gov Identifier: NCT00347854 - Completed
  Healthy
  
• Fluoroscopy Guided Femoral Arterial Access.
  ClinicalTrials.gov Identifier: NCT00222430 - Active, not recruiting
  Coronary Angiography
  
• Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016042 - Active, not recruiting
  recurrent colon cancer; Stage IV Renal Cell Cancer; Stage IV rectal cancer; recurrent rectal cancer; recurrent renal cell cancer; ...
  
• Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
  ClinicalTrials.gov Identifier: NCT00091312 - Active, not recruiting
  stage II colon cancer; adenocarcinoma of the colon
  
• Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
  ClinicalTrials.gov Identifier: NCT00425152 - Active, not recruiting
  Colorectal Cancer
  
• Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
  ClinicalTrials.gov Identifier: NCT00077233 - Active, not recruiting
  adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent colon cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00026273 - Active, not recruiting
  adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; adenocarcinoma of the colon
  
• Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004885 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; Quality of Life; ...
  
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00016198 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer
  ClinicalTrials.gov Identifier: NCT00083109 - Active, not recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• Fluorouracil Filtering Surgery Study (FFSS)
  ClinicalTrials.gov Identifier: NCT00000122 - Completed
  Glaucoma
  
• Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003175 - Active, not recruiting
  recurrent transitional cell cancer of the renal pelvis and ureter; recurrent urethral cancer; childhood kidney/urinary cancer; ...
  
• Fluorouracil Plus Ethynyluracil in Treating Patients With Advanced Colorectal Cancer That Has Not Responded to Fluorouracil
  ClinicalTrials.gov Identifier: NCT00003254 - Active, not recruiting
  recurrent colon cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors
  ClinicalTrials.gov Identifier: NCT00002470 - Completed
  metastatic gastrointestinal carcinoid tumor; recurrent gastrointestinal carcinoid tumor; pulmonary carcinoid tumor
  
• Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00004931 - Active, not recruiting
  stage III colon cancer; stage II colon cancer
  
• Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004059 - Completed
  unspecified adult solid tumor, protocol specific
  
• Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003873 - Active, not recruiting
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00006112 - Active, not recruiting
  adenocarcinoma of the rectum; childhood gastrointestinal cancer; peritoneal cavity cancer; Stage IV rectal cancer; carcinoma of the appendix; ...
  
• Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer
  ClinicalTrials.gov Identifier: NCT00093665 - Active, not recruiting
  stage II lymphoepithelioma of the nasopharynx; stage III lymphoepithelioma of the nasopharynx; stage IV lymphoepithelioma of the nasopharynx; ...
  
• Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00304135 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
  
• Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00544362 - Recruiting
  Esophageal Cancer
  
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00462735 - Recruiting
  Head and Neck Cancer; Cancer of the Pharynx; Cancer of the Larynx; Nose Neoplasms; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
  
• Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00075738 - Active, not recruiting
  stage IV esophageal cancer; recurrent esophageal cancer
  
• Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00075595 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00096278 - Active, not recruiting
  adenocarcinoma of the colon; stage II colon cancer; stage III colon cancer
  
• Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
  ClinicalTrials.gov Identifier: NCT00082706 - Recruiting
  Bladder Cancer; Urethral Cancer
  
• Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00514020 - Recruiting
  Gastric Cancer
  
• Fluorouracil, Phenylbutyrate, Indomethacin, and Interferon Gamma in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00002796 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00427570 - Completed
  Colorectal Cancer
  
• Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004860 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; ...
  
• Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005608 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
  ClinicalTrials.gov Identifier: NCT00449007 - Recruiting
  Depression; Alcoholism; Suicidal Behavior
  
• Fluoxetine as a Quit Smoking AID for Depression Prone
  ClinicalTrials.gov Identifier: NCT00113737 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
  ClinicalTrials.gov Identifier: NCT00018174 - Completed
  Smoking; Depression
  
• Fluoxetine for Anxious Children
  ClinicalTrials.gov Identifier: NCT00000381 - Completed
  Anxiety Disorders
  
• Fluoxetine in Pediatric Body Dysmorphic Disorder
  ClinicalTrials.gov Identifier: NCT00245635 - Recruiting
  Body Dysmorphic Disorder
  
• Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa
  ClinicalTrials.gov Identifier: NCT00288574 - Completed
  Anorexia Nervosa; Eating Disorders
  
• Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
  ClinicalTrials.gov Identifier: NCT00000379 - Completed
  Stress Disorders, Post-Traumatic
  
• Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
  ClinicalTrials.gov Identifier: NCT00000274 - Completed
  Cocaine-Related Disorders; Substance-Related Disorders
  
• Flupenthixol Decanoate in Methamphetamine Smoking - 1
  ClinicalTrials.gov Identifier: NCT00000241 - Completed
  Substance-Related Disorders
  
• Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
  ClinicalTrials.gov Identifier: NCT00000266 - Completed
  Cocaine-Related Disorders
  
• Fluphenazine Decanoate for Psoriasis
  ClinicalTrials.gov Identifier: NCT00356200 - Recruiting
  Psoriasis
  
• Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00335647 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Flushes and Sertraline Trial
  ClinicalTrials.gov Identifier: NCT00283192 - Completed
  Menopause-Hot Flashes
  
• Flushing in Social Anxiety Disorder on Cipralex
  ClinicalTrials.gov Identifier: NCT00485888 - Not yet recruiting
  Social Anxiety Disorder
  
• Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate
  ClinicalTrials.gov Identifier: NCT00006214 - Completed
  Quality of Life; prevention of prostate cancer
  
• Flutamide With or Without Vaccine Therapy in Treating Patients With Nonmetastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00450463 - Recruiting
  Prostate Cancer
  
• Flutamide, Suramin, and Hydrocortisone in Treating Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002881 - Completed
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
  ClinicalTrials.gov Identifier: NCT00502775 - Recruiting
  Allergic Rhinitis; Hay Fever
  
• Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
  ClinicalTrials.gov Identifier: NCT00435461 - Active, not recruiting
  Hayfever; Allergic Rhinitis
  
• Fluticasone Nasal Spray Patient Preference Study
  ClinicalTrials.gov Identifier: NCT00398476 - Active, not recruiting
  Allergic Rhinitis
  
• Fluvastatin After Heart Transplantation
  ClinicalTrials.gov Identifier: NCT00421005 - Recruiting
  Heart Transplantation; Hypercholesterolemia
  
• Fluvastatin in the Therapy of Acute Coronary Syndrome
  ClinicalTrials.gov Identifier: NCT00171275 - Completed
  Coronary Disease; Myocardial Infarction
  
• Fluvastatin Versus Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00441493 - Active, not recruiting
  Hepatitis C
  
• Fluvoxamine Maleate in the Treatment of Depression/Depressive State: A Post-Marketing Clinical Study in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00353028 - Recruiting
  Major Depressive Disorder
  
• Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-Marketing Clinical Study in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00352768 - Recruiting
  Obsessive Compulsive Disorder
  
• FM 140 vs FM100 Study in Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00505895 - Recruiting
  Multiple Myeloma
  
• FMAS - Faslodex in McCune Albright Syndrome
  ClinicalTrials.gov Identifier: NCT00278915 - Recruiting
  Puberty, Precocious; McCune-Albright Syndrome
  
• FMP2.1 Trial in Bandiagara, Mali
  ClinicalTrials.gov Identifier: NCT00349713 - Completed
  Malaria; Plasmodium Falciparum Malaria
  
• fMRI in Posttraumatic Stress Disorder (PTSD) During Working Memory Updating
  ClinicalTrials.gov Identifier: NCT00288314 - Recruiting
  Post-Traumatic Stress Disorders; Anxiety; Amnesia, Dissociative
  
• fMRI Investigation of Depression in Patients With Epilepsy
  ClinicalTrials.gov Identifier: NCT00532376 - Recruiting
  Epilepsy; Depression
  
• FMRI of Memory in Children
  ClinicalTrials.gov Identifier: NCT00242905 - Recruiting
  Childhood Epilepsy
  
• fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00478491 - Enrolling by invitation
  Magnetic Resonance Imaging; Alzheimer's Disease; Dementia; Adult Children; Risk
  
• fMRI Studies of Task Specificity in Focal Hand Dystonia
  ClinicalTrials.gov Identifier: NCT00310414 - Recruiting
  Focal Dystonia
  
• fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00332046 - Terminated
  Social Anxiety Disorder
  
• fMRI Study of Brain Neural Network and Plasticity After Stroke
  ClinicalTrials.gov Identifier: NCT00530647 - Recruiting
  Stroke
  
• fMRI Study of Grasping in Autistic Patients
  ClinicalTrials.gov Identifier: NCT00245778 - Terminated
  Autistic Disorder
  
• FMRI Study of Performance During a Probabilistic Reversal Learning Task in Depression
  ClinicalTrials.gov Identifier: NCT00075296 - Active, not recruiting
  Major Depressive Disorder
  
• FMRI-SAM and Alzheimer’s Disease
  ClinicalTrials.gov Identifier: NCT00412048 - Recruiting
  Alzheimer’s Disease
  
• FNS and Weight Support Treadmill Training for Gait Component Restoration
  ClinicalTrials.gov Identifier: NCT00011596 - Completed
  Stroke
  
• Focal In-Stent Restenosis After Drug-Eluting Stent
  ClinicalTrials.gov Identifier: NCT00485004 - Recruiting
  In-Stent Restenosis
  
• FOCUS Fatigue Outcome in Copaxone USers
  ClinicalTrials.gov Identifier: NCT00267319 - Active, not recruiting
  Multiple Sclerosis
  
• Focus on Function Study for Children With Cerebral Palsy
  ClinicalTrials.gov Identifier: NCT00469872 - Recruiting
  Cerebral Palsy
  
• FOCUS:Focus On Coronary Unstable Syndromes
  ClinicalTrials.gov Identifier: NCT00268619 - Completed
  Myocardial Ischemia
  
• Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa
  ClinicalTrials.gov Identifier: NCT00494858 - Recruiting
  Eating Disorders
  
• Folate and Protection Against Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00220532 - Terminated
  Cervical Cancer
  
• Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial
  ClinicalTrials.gov Identifier: NCT00514410 - Recruiting
  Depression
  
• Folate Supplementation in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00249288 - Recruiting
  Schizophrenia
  
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00096330 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture
  ClinicalTrials.gov Identifier: NCT00290199 - Recruiting
  Fetal Membranes, Premature Rupture; Labor, Induced/IS
  
• FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00323011 - Recruiting
  Colorectal Cancer
  
• FOLFIRI Plus Cetuximab Versus Bevacizumab in First Line Treatment CRC
  ClinicalTrials.gov Identifier: NCT00433927 - Recruiting
  Neoplasm Metastasis; Colorectal Cancer
  
• FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00501410 - Recruiting
  Colorectal Cancer
  
• Folfox-B Study for Patients With Colorectal Liver Metastases
  ClinicalTrials.gov Identifier: NCT00508872 - Recruiting
  Colorectal Liver Metastases
  
• FOLFOX-Cetuximab-Radiotherapy for the Treatment of Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00578201 - Recruiting
  Stage III Esophageal Cancer
  
• FOLFOX4 in Patients with Normal and Abnormal Renal Function
  ClinicalTrials.gov Identifier: NCT00094965 - Completed
  Gastrointestinal Cancer
  
• Folic Acid and Omega -3 Fatty Acid Supplementation in Depressed Older Adults
  ClinicalTrials.gov Identifier: NCT00480207 - Recruiting
  Depression
  
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
  ClinicalTrials.gov Identifier: NCT00064753 - Active, not recruiting
  Renal transplant recipients
  
• Folic Acid in Preventing Colorectal Polyps in Patients With Previous Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00512850 - Active, not recruiting
  Colorectal Cancer
  
• Folic Acid Supplementation in Gambian Primigravidae
  ClinicalTrials.gov Identifier: NCT00120822 - Completed
  Malaria
  
• Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men with Hypogonadism
  ClinicalTrials.gov Identifier: NCT00064987 - Recruiting
  Hypogonadism; Kallmann Syndrome
  
• Follow Up and Observation of Charcot Marie Tooth Disease in Families
  ClinicalTrials.gov Identifier: NCT00149045 - Completed
  Charcot-Marie-Tooth Disease
  
• Follow Up at School-Age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
  ClinicalTrials.gov Identifier: NCT00152542 - Active, not recruiting
  Prematurity, Respiratory distress syndrome,Hypoxemia
  
• Follow Up Freestyle Valve
  ClinicalTrials.gov Identifier: NCT00385112 - Recruiting
  Right Ventricular Outflow Tract; Pulmonary Valve Stenosis; Pulmonary Valve Atresia
  
• Follow Up Glucose Levels Among Infants of Diabetic Mothers
  ClinicalTrials.gov Identifier: NCT00337142 - Not yet recruiting
  Newborn; Full Term; Diabetic Mother
  
• Follow up of Autoantibodies in Active Tuberculosis
  ClinicalTrials.gov Identifier: NCT00551226 - Not yet recruiting
  Tuberculosis
  
• Follow Up of Patients Treated with Radiotherapy
  ClinicalTrials.gov Identifier: NCT00026650 - Recruiting
  Neoplasm
  
• Follow up of Post-Repair Tetralogy of Fallot
  ClinicalTrials.gov Identifier: NCT00266188 - Active, not recruiting
  Tetralogy of Fallot
  
• Follow up of Schizophrenic Patients Following Treatment Discontinuation After Remission From a First Psychotic Episode
  ClinicalTrials.gov Identifier: NCT00378092 - Active, not recruiting
  Schizophrenia
  
• Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine Trial
  ClinicalTrials.gov Identifier: NCT00337181 - Recruiting
  HIV-1
  
• Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
  ClinicalTrials.gov Identifier: NCT00537017 - Not yet recruiting
  Parkinson Disease; Neurodegenerative Diseases; Central Nervous System Diseases; Movement Disorders; Brain Diseases
  
• Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175
  ClinicalTrials.gov Identifier: NCT00291655 - Active, not recruiting
  Epilepsy
  
• Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
  ClinicalTrials.gov Identifier: NCT00344175 - Active, not recruiting
  Hypercholesterolemia; Dyslipidemia; Coronary Heart Disease
  
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00344370 - Active, not recruiting
  Type II Diabetes Mellitus; Dyslipidemia
  
• Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm
  ClinicalTrials.gov Identifier: NCT00488943 - Recruiting
  Abdominal Aortic Aneurysm
  
• Follow-up After Surgery for Colon Cancer. General Practice vs. Surgical-Based Follow-up?
  ClinicalTrials.gov Identifier: NCT00572143 - Recruiting
  Colon Cancer
  
• Follow-Up Assessment of Subjects Who Received Ganciclovir for CMV Infections
  ClinicalTrials.gov Identifier: NCT00031421 - Active, not recruiting
  Cytomegalovirus Infections
  
• Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely
  ClinicalTrials.gov Identifier: NCT00390065 - Recruiting
  Premature Birth
  
• Follow-Up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis
  ClinicalTrials.gov Identifier: NCT00124436 - Active, not recruiting
  ...
  
• Follow-up Evaluation of Home Nurse Visitation Program for Socially Disadvantaged Women and Their Children
  ClinicalTrials.gov Identifier: NCT00443586 - Recruiting
  Risk Reduction Behavior
  
• Follow-Up Evaluation of Patients With Solid Tumors Previously Enrolled in a Vaccine Therapy Clinical Trial
  ClinicalTrials.gov Identifier: NCT00451022 - Recruiting
  Breast Cancer; Colorectal Cancer; Long-Term Effects Secondary to Cancer Therapy in Adults; Metastatic Cancer; Ovarian Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer
  ClinicalTrials.gov Identifier: NCT00553371 - Recruiting
  Testicular Germ Cell Tumor
  
• Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-Induced Seasonal Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00325338 - Completed
  Type I Hypersensitivity
  
• Follow-Up Modalities of Low Grade Precancerous Bronchial Lesions
  ClinicalTrials.gov Identifier: NCT00213603 - Active, not recruiting
  Precancerous Lesions Lung
  
• Follow-Up of Eating Disorder Patients From a 15-Year Period.
  ClinicalTrials.gov Identifier: NCT00184314 - Completed
  Eating Disorder Symptoms
  
• Follow-up of Endovascular Aneurysm Treatment - The FEAT Trial
  ClinicalTrials.gov Identifier: NCT00281411 - Recruiting
  Aortic Aneurysm, Abdominal
  
• Follow-up of Families in Early Preventive Intervention
  ClinicalTrials.gov Identifier: NCT00438516 - Active, not recruiting
  Child Rearing; Adolescent Development; Reproductive Behavior; Risk Reduction Behavior
  
• Follow-up of Patients After 4-Row Arthrodesis or Proximal Row Carpectomy
  ClinicalTrials.gov Identifier: NCT00284310 - Recruiting
  Wrist Surgery: 4-Corner Arthrodesis or Proximal Row Carpectomy
  
• Follow-up of Patients After Knee Arthrodesis With an Intramedullary Nail
  ClinicalTrials.gov Identifier: NCT00284297 - Recruiting
  Knee Arthrodesis With Intramedullary Nail
  
• Follow-Up of Patients With Breast Cancer or Multiple Myeloma Previously Treated on a Gene Therapy Clinical Trial
  ClinicalTrials.gov Identifier: NCT00427726 - Active, not recruiting
  Breast Cancer; Multiple Myeloma and Plasma Cell Neoplasm
  
• Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC
  ClinicalTrials.gov Identifier: NCT00199615 - Completed
  Non-Small Cell Lung Cancer
  
• Follow-up of Psychological and Neurocognitive Gulf War Outcome: Relation to Stress
  ClinicalTrials.gov Identifier: NCT00018707 - Completed
  Gulf War Syndrome
  
• Follow-Up of VLBW Infants With Chronic Lung Disease: Respiratory Health and Neurodevelopment
  ClinicalTrials.gov Identifier: NCT00358891 - Not yet recruiting
  Premature Birth
  
• Follow-Up Phone Calls After Colorectal Surgery
  ClinicalTrials.gov Identifier: NCT00474097 - Recruiting
  Colorectal Surgery; Colorectal Neoplasms; Colitis, Ulcerative; Diverticulitis; Colonic Polyps
  
• Follow-up Protocol for Patients with Cancer/AIDS/Skin Disease
  ClinicalTrials.gov Identifier: NCT00001503 - Recruiting
  Acquired Immunodeficiency Syndrome; Neoplasm; Skin Disease; HIV Infections
  
• Follow-Up Serial Infusions of Natrecor(R) (nesiritide) for the Management of Patients with Heart Failure-FUSION II
  ClinicalTrials.gov Identifier: NCT00091520 - Completed
  Heart Failure, Congestive
  
• Follow-up study for men diagnosed with prostate cancer through participation in a prostate specific antigen screening program
  ClinicalTrials.gov Identifier: NCT00035217 - Completed
  Prostate Cancer
  
• Follow-Up Study of Extremely Low Birth Weight (ELBW) Infants
  ClinicalTrials.gov Identifier: NCT00009633 - Recruiting
  Infant, Newborn, Diseases
  
• Follow-Up Study of GlaxoSmithKline Biologicals'' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults
  ClinicalTrials.gov Identifier: NCT00120848 - Active, not recruiting
  Papillomavirus infections
  
• Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
  ClinicalTrials.gov Identifier: NCT00160615 - Active, not recruiting
  Epilepsy, Partial
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00098150 - Completed
  Atopic Dermatitis
  
• Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
  ClinicalTrials.gov Identifier: NCT00098189 - Completed
  Psoriasis
  
• Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00560365 - Recruiting
  Colorectal Cancer
  
• Follow-Up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107
  ClinicalTrials.gov Identifier: NCT00149916 - Active, not recruiting
  Renal transplant
  
• Follow-Up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301
  ClinicalTrials.gov Identifier: NCT00149929 - Active, not recruiting
  Renal transplant
  
• Follow-Up Study of Safety of Enteric-Coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
  ClinicalTrials.gov Identifier: NCT00149864 - Active, not recruiting
  Renal transplant
  
• Follow-Up Study of Thai Children From Dengue-003 and Evaluation of a Booster Dose of Dengue Vaccine
  ClinicalTrials.gov Identifier: NCT00318916 - Completed
  Dengue
  
• Follow-up Study of the BENEFIT Study (Betaferon® / Betaseron® in Newly Emerging Multiple Sclerosis for Initial Treatment)
  ClinicalTrials.gov Identifier: NCT00185211 - Active, not recruiting
  Multiple Sclerosis
  
• Follow-up Study of the RAI-Treated Hyperthyroid Patients
  ClinicalTrials.gov Identifier: NCT00471458 - Completed
  Hyperthyroidism; Cardiovascular Diseases; Atrial Fibrillation
  
• Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma
  ClinicalTrials.gov Identifier: NCT00463138 - Not yet recruiting
  Healthy
  
• Follow-Up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
  ClinicalTrials.gov Identifier: NCT00161941 - Completed
  Meningococcal Meninigitis, Serogroup C
  
• Follow-up Study to Evaluate the Long-Term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
  ClinicalTrials.gov Identifier: NCT00518336 - Recruiting
  HPV-16/18 Infections; Cervical Neoplasia
  
• Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
  ClinicalTrials.gov Identifier: NCT00546078 - Recruiting
  Human Papillomavirus Infection
  
• Follow-up Study to Evaluate the Safety of Prochymal for the Treatment of GVHD Patients
  ClinicalTrials.gov Identifier: NCT00476762 - Active, not recruiting
  Graft Versus Host Disease
  
• Follow-up Study to Previous CARE Trial
  ClinicalTrials.gov Identifier: NCT00479024 - Recruiting
  Moderate to Severe Kidney Disease
  
• Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00463619 - Active, not recruiting
  Ulcerative Colitis
  
• Follow-Up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering from Partial Onset Seizures.
  ClinicalTrials.gov Identifier: NCT00175916 - Recruiting
  Epilepsy, Partial
  
• Following Patients on Warfarin Therapy to see if Differences in Hemorrhagic Complications Exist
  ClinicalTrials.gov Identifier: NCT00075985 - Completed
  Atrial Fibrillation
  
• Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00476216 - Not yet recruiting
  Non-Small Cell Lung Cancer; Venous Thromboembolism
  
• Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
  ClinicalTrials.gov Identifier: NCT00256100 - Recruiting
  Patients Requiring Haemofiltration for Acute Renal Failure.
  
• Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
  ClinicalTrials.gov Identifier: NCT00413504 - Completed
  Deep Vein Thrombosis; Pulmonary Embolism
  
• Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00381888 - Recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Gestational Trophoblastic Tumor; Ovarian Cancer; Perioperative/Postoperative Complications; Sarcoma; Thromboembolism; Vaginal Cancer; Vulvar Cancer
  
• FOndaparinux in ST Elevation Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00064428 - Completed
  Myocardial Infarction
  
• Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study
  ClinicalTrials.gov Identifier: NCT00474591 - Not yet recruiting
  Coronary Bypass Graft Failure/Occlusion
  
• Food Incentives for TB Treatment Compliance in East Timor (FITTCET)
  ClinicalTrials.gov Identifier: NCT00192556 - Completed
  Tuberculosis
  
• Food Intake and Appetite in the Children of Mothers With Diabetes
  ClinicalTrials.gov Identifier: NCT00339313 - Recruiting
  Diabetes
  
• Food Rheology and Feeding in Lean and Obese Humans
  ClinicalTrials.gov Identifier: NCT00260130 - Recruiting
  Obesity; Overweight; Diabetes
  
• Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial
  ClinicalTrials.gov Identifier: NCT00455494 - Recruiting
  Malaria
  
• Foot and Ankle Edema Post-Cesarean Delivery
  ClinicalTrials.gov Identifier: NCT00488956 - Active, not recruiting
  Foot and Ankle Edema
  
• Foot and Ankle Range of Motion (Stretching) Apparatus
  ClinicalTrials.gov Identifier: NCT00527748 - Not yet recruiting
  Plantar Fasciitis; Flatfoot; Calcaneal Fractures; Ankle Fractures; Elderly Patients
  
• Foot Posture in People With Paralysis on One Side After Stroke
  ClinicalTrials.gov Identifier: NCT00308035 - Active, not recruiting
  Stroke
  
• For Prevention of Diarrhea in Patients Diagnosed with Metastatic Colorectal Cancer Treated with Chemotherapy
  ClinicalTrials.gov Identifier: NCT00037180 - Terminated
  Neoplasm Metastasis; Colorectal Neoplasms
  
• FORCE (Falls, Fracture, and Osteoporosis Risk Control Evaluation) Study
  ClinicalTrials.gov Identifier: NCT00465387 - Completed
  Osteoporosis
  
• Forced Air Versus Endovascular Warming in Polytrauma Patients
  ClinicalTrials.gov Identifier: NCT00555126 - Not yet recruiting
  Polytrauma; Hypothermia
  
• Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients
  ClinicalTrials.gov Identifier: NCT00298454 - Terminated
  Renal Failure; Critically Ill
  
• Forced Inspiratory Flow Volume Curve in Healthy Young Children
  ClinicalTrials.gov Identifier: NCT00533715 - Completed
  Healthy
  
• Forced Oscillation Technique (FOT) and Expiratory Flow Limitation (EFL)
  ClinicalTrials.gov Identifier: NCT00499304 - Recruiting
  Expiratory Flow Limitation; COPD; Breathing Artifacts
  
• Forearm Vascular Relaxation
  ClinicalTrials.gov Identifier: NCT00182923 - Active, not recruiting
  Healthy
  
• Forefoot Adduction (FFA) in Infants and Toddlers. Differences of Neuromuscular Activity.
  ClinicalTrials.gov Identifier: NCT00470756 - Not yet recruiting
  Forefoot Adduction
  
• Foreshortened Esophagus and Its Surgical Therapy
  ClinicalTrials.gov Identifier: NCT00507377 - Active, not recruiting
  Gastroesophageal Reflux Disease; Hiatal Hernia
  
• Formation and Severity of Pressure Ulcers Associated With 4% Albumin Vs. 0.9% Sodium Chloride
  ClinicalTrials.gov Identifier: NCT00228657 - Active, not recruiting
  Pressure Ulcer, Area; Pressure Ulcer, Grade; Albumin Level; Risk Score; Length of ICU Stay
  
• Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00098332 - Active, not recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00289562 - Suspended
  B-Cell Acute Lymphoblastic Leukemia
  
• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00501735 - Recruiting
  T-Cell Lymphoma
  
• FORT-T Trial -- Infertility Therapy for Women Age Forty and Older
  ClinicalTrials.gov Identifier: NCT00246506 - Recruiting
  Infertility
  
• Fortovase (Saquinavir) Given with Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
  ClinicalTrials.gov Identifier: NCT00000920 - Completed
  HIV Infections; Pregnancy
  
• Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
  ClinicalTrials.gov Identifier: NCT00221312 - Recruiting
  Perimenopausal Bone Loss
  
• Fosamax for Childhood Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00391404 - Recruiting
  Osteoporosis
  
• Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00000726 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Fostering Mothers’ Emotionally Responsive Parenting
  ClinicalTrials.gov Identifier: NCT00319436 - Recruiting
  Maternal Substance Use; Child Abuse
  
• Fotemustine in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00560118 - Recruiting
  Melanoma (Skin)
  
• FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
  ClinicalTrials.gov Identifier: NCT00414635 - Recruiting
  HIV Infections
  
• Fotonovela for Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00472095 - Not yet recruiting
  Type 2 Diabetes
  
• Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00540345 - Recruiting
  Chronic Hepatitis C; Genotype
  
• Four Week Safety and Efficacy Study with a Topical Gel to Treat Common Warts in Adults
  ClinicalTrials.gov Identifier: NCT00115141 - Completed
  Warts
  
• Four Week Safety and Efficacy Study with a Topical Gel to Treat Common Warts in Pediatric Subjects
  ClinicalTrials.gov Identifier: NCT00116675 - Completed
  Warts
  
• Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00006617 - Active, not recruiting
  HIV Infections
  
• Four-Week Omeprazole Treatment of Non-Erosive Reflux Disease in a Japanese Population
  ClinicalTrials.gov Identifier: NCT00259077 - Completed
  Non-Erosive Reflux Disease
  
• FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079443 - Completed
  recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent small lymphocytic lymphoma
  
• FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
  ClinicalTrials.gov Identifier: NCT00098644 - Recruiting
  Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
  
• FR901228 and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00089336 - Not yet recruiting
  B-cell Chronic Lymphocytic Leukemia; refractory chronic lymphocytic leukemia
  
• FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia
  ClinicalTrials.gov Identifier: NCT00053963 - Completed
  childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors; Leukemia
  
• FR901228 in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00248599 - Not yet recruiting
  Adult Solid Tumor; Leukemia; Lymphoma; Small Intestine Cancer
  
• FR901228 in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00087295 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• FR901228 in Treating Patients With Advanced Malignant Solid Tumors or Lymphomas and Liver Dysfunction
  ClinicalTrials.gov Identifier: NCT00253604 - Not yet recruiting
  Adult Solid Tumor; Leukemia; Lymphoma; Small Intestine Cancer
  
• FR901228 in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00024180 - Completed
  Waldenstrom's Macroglobulinemia; recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• FR901228 in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00084461 - Active, not recruiting
  gastrointestinal carcinoid tumor; Islet Cell Carcinoma; pulmonary carcinoid tumor
  
• FR901228 in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00098397 - Completed
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• FR901228 in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00112463 - Suspended
  adult soft tissue sarcoma; gastrointestinal stromal tumor; metastatic tumors of the Ewing''s family; tumors of the Ewing''s family
  
• FR901228 in Treating Patients With Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00060216 - Recruiting
  recurrent renal cell cancer; Stage IV Renal Cell Cancer
  
• FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00042822 - Active, not recruiting
  adult acute myeloid leukemia; adult non-Hodgkin's lymphoma; atypical chronic myeloid leukemia; ...
  
• FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00077337 - Completed
  recurrent colon cancer; stage III colon cancer; stage IV colon cancer; recurrent rectal cancer; stage III rectal cancer; Stage IV rectal cancer
  
• FR901228 in Treating Patients With Progressive High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00085540 - Recruiting
  recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult anaplastic astrocytoma; Mixed Gliomas; adult gliosarcoma; ...
  
• FR901228 in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
  ClinicalTrials.gov Identifier: NCT00098813 - Recruiting
  stage IV follicular thyroid cancer; stage IV papillary thyroid cancer; recurrent thyroid cancer
  
• FR901228 in Treating Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00088920 - Not yet recruiting
  adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
  
• FR901228 in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00091195 - Completed
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• FR901228 in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00086827 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00020202 - Completed
  Extensive Stage Small Cell Lung Cancer; Stage IIIA Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Recurrent Non-Small Cell Lung Cancer
  
• FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00098527 - Suspended
  adenocarcinoma of the stomach; recurrent gastric cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer
  
• FR901228 in Treating Patients With Refractory Thyroid Cancer or Other Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00052767 - Recruiting
  Head and Neck Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• FR901228 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00062075 - Active, not recruiting
  adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00085527 - Completed
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00066638 - Active, not recruiting
  stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
  
• FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00077194 - Completed
  recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma; recurrent adult Burkitt's lymphoma
  
• FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00383565 - Recruiting
  Lymphoma
  
• FR901228 in Treating Patients With T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00020436 - Recruiting
  adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• FR901228 in Treating Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma (Cancer) of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084682 - Recruiting
  Head and Neck Cancer
  
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine
  ClinicalTrials.gov Identifier: NCT00271479 - Completed
  Infections, Meningococcal; Meningitis, Meningococcic
  
• Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
  ClinicalTrials.gov Identifier: NCT00267774 - Active, not recruiting
  Coronary Artery Disease
  
• Fractional Flow Reserve-Guided Provisional Side Branch Intervention
  ClinicalTrials.gov Identifier: NCT00351780 - Active, not recruiting
  Coronary Artery Disease
  
• Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies
  ClinicalTrials.gov Identifier: NCT00239239 - Completed
  Non-Myeloid Malignancies; Anemia; Cancer
  
• Fracture of Distal Radius and Ulna Healed With Shortening of One Bone. Clinical Significance at Skeletal Maturity
  ClinicalTrials.gov Identifier: NCT00492154 - Not yet recruiting
  Forearm Injuries
  
• Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
  ClinicalTrials.gov Identifier: NCT00239980 - Recruiting
  Ovarian Cancer
  
• Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
  ClinicalTrials.gov Identifier: NCT00480636 - Not yet recruiting
  Venous Thrombosis
  
• FRAGRANCE Part A Safety: Study to Find a Genetic Signature of de Novo Resistance to Letrozole
  ClinicalTrials.gov Identifier: NCT00199134 - Recruiting
  Breast Cancer
  
• FRALYSE Trial
  ClinicalTrials.gov Identifier: NCT00132509 - Recruiting
  Acute ischemic stroke
  
• Framing Messages for Smoking Cessation with Bupropion - 6
  ClinicalTrials.gov Identifier: NCT00104598 - Active, not recruiting
  Tobacco Use Disorder
  
• Framingham Children's Study - Food and Exercise Habits in Framingham Study Descendents
  ClinicalTrials.gov Identifier: NCT00005330 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Framingham Cycle V Offspring-Spouse Nutrition Studies
  ClinicalTrials.gov Identifier: NCT00005347 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Hypertension; Obesity; Diabetes Mellitus; Atherosclerosis
  
• Framingham Heart Study
  ClinicalTrials.gov Identifier: NCT00005121 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Cerebrovascular Accident; Hypertension; Heart Failure, Congestive; ...
  
• Framingham Nutrition Studies
  ClinicalTrials.gov Identifier: NCT00005513 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Hypertension
  
• Framingham Offspring Study: Psychosocial Risk Factors
  ClinicalTrials.gov Identifier: NCT00037323 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Depression; Atrial Fibrillation
  
• Framingham: Inflammation, Genes & Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00083863 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Inflammation
  
• Free Dronabinol Treatment for Marijuana Addiction
  ClinicalTrials.gov Identifier: NCT00217971 - Recruiting
  Marijuana Abuse
  
• Free Fatty Acids and Vascular Function in Subjects with Diabetes
  ClinicalTrials.gov Identifier: NCT00153179 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva
  ClinicalTrials.gov Identifier: NCT00426062 - Recruiting
  Squamous Cell Carcinoma
  
• FREE Study - Fracture Reduction Evaluation
  ClinicalTrials.gov Identifier: NCT00211211 - Active, not recruiting
  Osteopenia; Osteoporosis; Multiple Myeloma; Bone Neoplasms
  
• FREE Study: Efficacy and Toxicity of Trizivir
  ClinicalTrials.gov Identifier: NCT00405925 - Recruiting
  HIV Infections
  
• Free Test Strips and Blood Glucose Control
  ClinicalTrials.gov Identifier: NCT00205335 - Active, not recruiting
  Diabetes
  
• Free Treatment for Cocaine Dependence: A Placebo-Controlled Study of Mixed Amphetamine Salts (Adderall-XR) and Topiramate for the Treatment of Cocaine Dependence
  ClinicalTrials.gov Identifier: NCT00421603 - Recruiting
  Cocaine Dependence
  
• Free-Living Physical Activity and Energy Expenditure
  ClinicalTrials.gov Identifier: NCT00062998 - Completed
  Obesity
  
• FREEDOM - A Frequent Optimization Study Using the QuickOpt Method
  ClinicalTrials.gov Identifier: NCT00418314 - Recruiting
  Patient Has a Standard Indication for a CRT-D
  
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
  ClinicalTrials.gov Identifier: NCT00325403 - Recruiting
  Pulmonary Hypertension
  
• Freedom Study: Myfortic in Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00101738 - Active, not recruiting
  Kidney Transplantation
  
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
  ClinicalTrials.gov Identifier: NCT00325442 - Recruiting
  Pulmonary Hypertension
  
• FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
  ClinicalTrials.gov Identifier: NCT00288613 - Recruiting
  Kidney Failure, Chronic; End Stage Renal Disease, Requiring Dialysis
  
• French-Canadian Version of the Wheelchair Skills Program (WSP)
  ClinicalTrials.gov Identifier: NCT00400244 - Recruiting
  Disabled Persons
  
• Frequency of Accessing Central Lines for Blood Samples
  ClinicalTrials.gov Identifier: NCT00366314 - Terminated
  Congenital Disorders
  
• Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients
  ClinicalTrials.gov Identifier: NCT00351572 - Recruiting
  Colon Cancer
  
• Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis
  ClinicalTrials.gov Identifier: NCT00409734 - Recruiting
  Pyloric Stenosis
  
• Frequency of ICAM-1 Polymorphisms in Obese Subjects
  ClinicalTrials.gov Identifier: NCT00436488 - Completed
  Obesity
  
• Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
  ClinicalTrials.gov Identifier: NCT00001712 - Completed
  Hepatitis B; Hepatitis C; HIV Infection
  
• Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated with Radiotherapy
  ClinicalTrials.gov Identifier: NCT00123812 - Terminated
  Breast Cancer
  
• Frequency of Zoledronic Acid to Prevent Further Bone Loss in Osteoporotic Patients Requiring Androgen Deprivation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00520052 - Completed
  Osteoporosis
  
• Frequent Hemodialysis Network: Daily Trial
  ClinicalTrials.gov Identifier: NCT00264758 - Recruiting
  End Stage Renal Disease; Hemodialysis
  
• Frequent Hemodialysis Network: Nocturnal Trial
  ClinicalTrials.gov Identifier: NCT00271999 - Recruiting
  End Stage Renal Disease; Hemodialysis
  
• Fresh Frozen Plasma in Cardiac Surgery: Descriptive and Prognostic Study
  ClinicalTrials.gov Identifier: NCT00221741 - Completed
  Heart Surgery; Blood Loss, Surgical
  
• Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures
  ClinicalTrials.gov Identifier: NCT00233246 - Terminated
  Blood Coagulation Disorders
  
• Friendship Based HIV/STI (Sexually Transmitted Infections) Intervention for African American Females
  ClinicalTrials.gov Identifier: NCT00109421 - Completed
  Sexual Behavior; Sexually Transmitted Diseases; HIV Infections
  
• From Compliance to Alliance: Engaging Psychiatric Patients in Illness Management
  ClinicalTrials.gov Identifier: NCT00192751 - Recruiting
  Patients Diagnosed With Severe Mental Illness
  
• From Research to Practice - Lipid Management for Low HDL-Cholesterol
  ClinicalTrials.gov Identifier: NCT00057044 - Completed
  Coronary Heart Disease
  
• Frontier Registry II Bifurcation Stent System Registry
  ClinicalTrials.gov Identifier: NCT00286195 - Recruiting
  Coronary Artery Disease
  
• Frontotemporal Dementia and Amytrophic Lateral Sclerosis
  ClinicalTrials.gov Identifier: NCT00140777 - Recruiting
  Frontotemporal dementia; and/or; Lateral amyotrophic sclerosis
  
• FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries
  ClinicalTrials.gov Identifier: NCT00242892 - Active, not recruiting
  Percutaneous Transluminal Coronary Angioplasty With Stent
  
• Fructose Malabsorption in Northern Norway
  ClinicalTrials.gov Identifier: NCT00555191 - Recruiting
  Irritable Bowel Syndrome; Fructose Malabsorption
  
• Fructose-Induced Palmitate Synthesis in Overweight Subjects
  ClinicalTrials.gov Identifier: NCT00535535 - Recruiting
  Elevated Triglycerides; Diabetes; Cardiovascular Disease
  
• Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, Stage IVA, or Stage IVB Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00064298 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Fruit, Vegetables and Whole Grains: A Community-Based Intervention
  ClinicalTrials.gov Identifier: NCT00516620 - Recruiting
  Body Weight; Heart Disease; Diabetes; Hypertension
  
• Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.
  ClinicalTrials.gov Identifier: NCT00246675 - Not yet recruiting
  Renal Impairment After Cardiac Surgery
  
• FSGS Clinical Trial (FSGS-CT)
  ClinicalTrials.gov Identifier: NCT00135811 - Recruiting
  Glomerulosclerosis, Focal[C12.777.419.570.363.640]
  
• FSME IMMUN NEW Follow-Up to Study 199 in Children Aged 1 to 6 Years
  ClinicalTrials.gov Identifier: NCT00161850 - Completed
  Encephalitis, Tick-Borne
  
• FSME IMMUN NEW Follow-Up to Study 205 in Children Aged 6 to 16 Years
  ClinicalTrials.gov Identifier: NCT00161889 - Completed
  Encephalitis, Tick-Borne
  
• FSME IMMUN NEW Follow-Up to Study 208 in Volunteers Aged 16 to 66 Years
  ClinicalTrials.gov Identifier: NCT00161876 - Completed
  Encephalitis, Tick-Borne
  
• Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study
  ClinicalTrials.gov Identifier: NCT00286507 - Recruiting
  Stage 2 or 3 Full Thickness Macular Hole
  
• Full-Leg vs Below-Knee Elastic Stockings for Prevention of the Post-Thrombotic Syndrome
  ClinicalTrials.gov Identifier: NCT00426075 - Recruiting
  Deep Vein Thrombosis
  
• Full-Time Bangerter Filters Versus Part-Time Daily Patching for Moderate Amblyopia in Children
  ClinicalTrials.gov Identifier: NCT00525174 - Recruiting
  Amblyopia
  
• Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women with Estrogen Receptor Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00093002 - Completed
  Breast Cancer
  
• Fulvestrant (Faslodex) + Anastrozol (Arimidex) vs Anastrozol
  ClinicalTrials.gov Identifier: NCT00543127 - Not yet recruiting
  Breast Cancer
  
• Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00423917 - Suspended
  Breast Cancer
  
• Fulvestrant and/or Trastuzumab in Treating Postmenopausal Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00138125 - Recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
  ClinicalTrials.gov Identifier: NCT00334295 - Recruiting
  Endometrial Carcinoma
  
• Fulvestrant in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00476645 - Recruiting
  Prostate Cancer
  
• Fulvestrant in Premenopausal Women with Hormone Receptor-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00146601 - Completed
  Invasive Breast Cancer; Stage IV Breast Cancer; Hormone Receptor-Positive Breast Cancer
  
• Fulvestrant in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00244998 - Active, not recruiting
  Prostate Cancer
  
• Fulvestrant in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00217464 - Recruiting
  Prostate Cancer
  
• Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00006903 - Recruiting
  stage IV endometrial cancer; recurrent endometrial cancer
  
• Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00126464 - Active, not recruiting
  intraductal breast carcinoma; breast cancer in situ
  
• Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00253422 - Recruiting
  Breast Cancer
  
• Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive and Expresses HER2
  ClinicalTrials.gov Identifier: NCT00390455 - Recruiting
  Breast Cancer
  
• Function of Catecholamines in the Brain During Depression
  ClinicalTrials.gov Identifier: NCT00082030 - Active, not recruiting
  Depression; Involutional
  
• Function-Related Tests for Subjects With Stiff Shoulders: Reliability and Validity
  ClinicalTrials.gov Identifier: NCT00172653 - Recruiting
  Stiff Shoulder
  
• Functional and Metabolic Imaging Using Magnetic Resonance Imaging and Spectroscopy
  ClinicalTrials.gov Identifier: NCT00001591 - Completed
  Healthy; Nervous System Disease
  
• Functional and Molecular Characterisation of Oesophageal Distal Epithelium: Correlations With Acid and Non Acid Reflux
  ClinicalTrials.gov Identifier: NCT00231881 - Recruiting
  Gastro-Oesophageal Reflux
  
• Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy
  ClinicalTrials.gov Identifier: NCT00242060 - Recruiting
  Elevated PSA; Prostate Cancer
  
• Functional Assessment Questionnaire for the Visually Challenged
  ClinicalTrials.gov Identifier: NCT00407901 - Active, not recruiting
  Legally Blind
  
• Functional Behavioural Skill Training for Young Children With Severe Autism
  ClinicalTrials.gov Identifier: NCT00518804 - Recruiting
  Autistic Disorder
  
• Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment
  ClinicalTrials.gov Identifier: NCT00161057 - Recruiting
  Schizophrenia; Schizophreniform Disorder; Schizoaffective Disorder; psychotic disorder Not Otherwise Specified
  
• Functional Brain Imaging - Acupuncture and Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00070824 - Completed
  Osteoarthritis
  
• Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
  ClinicalTrials.gov Identifier: NCT00314613 - Recruiting
  Schizophrenia
  
• Functional Brain Imaging in Recreational Users of Ecstasy
  ClinicalTrials.gov Identifier: NCT00254306 - Recruiting
  Dependence on Ecstasy
  
• Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
  ClinicalTrials.gov Identifier: NCT00369603 - Recruiting
  Alzheimer's Disease
  
• Functional Characterization of Parkin + Patients
  ClinicalTrials.gov Identifier: NCT00142311 - Terminated
  Parkinson''s Disease
  
• Functional Circuit Training in Older Adults with Congestive Heart Failure
  ClinicalTrials.gov Identifier: NCT00108147 - Recruiting
  Heart Failure, Congestive
  
• Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
  ClinicalTrials.gov Identifier: NCT00457054 - Active, not recruiting
  Bipolar Depression
  
• Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections during Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control
  ClinicalTrials.gov Identifier: NCT00036595 - Completed
  Epilepsy
  
• Functional Dyspepsia - Effect of Acid-Reducing Treatment and Information on Various Types of Dysmotility
  ClinicalTrials.gov Identifier: NCT00437346 - Recruiting
  Dyspepsia
  
• Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke
  ClinicalTrials.gov Identifier: NCT00142792 - Recruiting
  Stroke, Acute; Stroke; Hemiparesis
  
• Functional Electrical Stimulation for Footdrop in Hemiparesis
  ClinicalTrials.gov Identifier: NCT00148343 - Recruiting
  Stroke; Hemiplegia
  
• Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00201968 - Recruiting
  Spinal Cord Injury
  
• Functional Evaluation of the Total Knee Prostheses:Rising from a Chair
  ClinicalTrials.gov Identifier: NCT00163228 - Recruiting
  Osteoarthritis, Knee; Osteoarthritis, Hip
  
• Functional Evaluation of Two Types of Totally Implanted Venous Ports
  ClinicalTrials.gov Identifier: NCT00484848 - Completed
  Oncology, Medical; Hematologic Disease
  
• Functional Genomic Influences on Disease Progression and Outcome in Sepsis Due to Pneumonia or Peritonitis
  ClinicalTrials.gov Identifier: NCT00131196 - Recruiting
  Pneumonia; Peritonitis
  
• Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00246116 - Active, not recruiting
  Non-Small-Cell Lung Cancer
  
• Functional Lipids and Appetite Regulation
  ClinicalTrials.gov Identifier: NCT00259259 - Completed
  Obesity
  
• Functional Magnetic Micturition in Patients w/SCI
  ClinicalTrials.gov Identifier: NCT00011557 - Completed
  Spinal Cord Injury
  
• Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism
  ClinicalTrials.gov Identifier: NCT00211783 - Recruiting
  Autism; Asperger's Syndrome
  
• Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
  ClinicalTrials.gov Identifier: NCT00211822 - Recruiting
  Pathological Gambling; Obsessive Compulsive Disorder
  
• Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
  ClinicalTrials.gov Identifier: NCT00005083 - Completed
  adult juvenile pilocytic astrocytoma; Adult Subependymal Astrocytoma; adult well-differentiated mildly and moderately anaplastic astrocytoma; ...
  
• Functional Magnetic Resonance Imaging in Infants
  ClinicalTrials.gov Identifier: NCT00008814 - Recruiting
  Healthy; Infant, Newborn, Diseases
  
• Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
  ClinicalTrials.gov Identifier: NCT00507546 - Recruiting
  Insomnia; Spinal Cord Injury; Tetraplegia; Sleep Disorders
  
• Functional MR Urography
  ClinicalTrials.gov Identifier: NCT00301470 - Not yet recruiting
  Ureteral Obstruction
  
• Functional MRI (fMRI) in CGRP Induced Migraine
  ClinicalTrials.gov Identifier: NCT00363532 - Not yet recruiting
  Migraine With Out Aura
  
• Functional MRI of Cognitive Control in Autism
  ClinicalTrials.gov Identifier: NCT00463164 - Not yet recruiting
  Autism
  
• Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
  ClinicalTrials.gov Identifier: NCT00580918 - Recruiting
  Mild Traumatic Brain Injury
  
• Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory
  ClinicalTrials.gov Identifier: NCT00458432 - Recruiting
  Healthy
  
• Functional Neuroimaging Effects of Cognitive Remediation Training
  ClinicalTrials.gov Identifier: NCT00481156 - Completed
  Schizophrenia
  
• Functional Neuroimaging in Depression
  ClinicalTrials.gov Identifier: NCT00343070 - Recruiting
  Major Depression
  
• Functional Outcome and MRI of Muscle Damage Following Nailing Procedure in Femur (Thigh) Fractures Using Different Entry Points
  ClinicalTrials.gov Identifier: NCT00471913 - Recruiting
  Femoral Shaft Fracture
  
• Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer
  ClinicalTrials.gov Identifier: NCT00579579 - Recruiting
  Rectal Cancer
  
• Functional Outcomes Following Limb Sparing Surgery for Soft Tissue Sarcoma and Pre-Operative Radiotherapy
  ClinicalTrials.gov Identifier: NCT00508339 - Recruiting
  Sarcoma
  
• Functional Outcomes in Cardiovascular Patients Undergoing Surgical Hip Fracture Repair (FOCUS)
  ClinicalTrials.gov Identifier: NCT00071032 - Recruiting
  Anemia; Blood Disease; Blood Transfusion; Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Thromboembolism; Pneumonia; ...
  
• Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan
  ClinicalTrials.gov Identifier: NCT00526084 - Recruiting
  Leukemia, Lymphocytic, Acute
  
• Functional Rehabilitation of Older Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00237796 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Psychotic Disorders
  
• Functional Surface Electromyogram of Knee Extensors in Healthy Humans and Patients With Patella-Dislocation.
  ClinicalTrials.gov Identifier: NCT00288847 - Active, not recruiting
  Patella-Dislocation
  
• Functioning, Disability, and Quality of Life in the Adult Hearing Impaired
  ClinicalTrials.gov Identifier: NCT00037986 - Completed
  Hearing impaired
  
• Functionnal Organization of Somatosensory Responses in the Secondary Somatosensitive Area and Insula
  ClinicalTrials.gov Identifier: NCT00542906 - Recruiting
  Healthy
  
• Fundus Autofluorescence Imaging in Age-Related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
  ClinicalTrials.gov Identifier: NCT00393692 - Recruiting
  Age-Related Macular Degeneration
  
• Funen Anorexia Nervosa Study - Retrospective Cohort Study and 10 Year Follow-Up Study
  ClinicalTrials.gov Identifier: NCT00267228 - Active, not recruiting
  Anorexia Nervosa; Eating Disorder
  
• Fungicide Exposure Assessment Among Apple and Peach Farmers in the Argicultural Health Study
  ClinicalTrials.gov Identifier: NCT00342394 - Active, not recruiting
  Pesticides; Occupational Exposure
  
• Funguria in Hospitalized Patients
  ClinicalTrials.gov Identifier: NCT00138502 - Active, not recruiting
  Candidiasis
  
• Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
  ClinicalTrials.gov Identifier: NCT00512811 - Completed
  Bronchiolitis
  
• Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System
  ClinicalTrials.gov Identifier: NCT00399217 - Recruiting
  Ventricular Fibrillation; Ventricular Tachycardia
  
• Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002174 - Completed
  HIV Infections
  
• Fusariosis in Solid-Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00518778 - Recruiting
  Solid Organ Transplant; Fusariosis
  
• FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR ® (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hos
  ClinicalTrials.gov Identifier: NCT00270361 - Completed
  Heart Failure, Congestive
  
• Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease
  ClinicalTrials.gov Identifier: NCT00086450 - Recruiting
  Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases
  
• Fuzeon (Enfuvirtide) Early Access Program for Patients with HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00050856 - Completed
  HIV Infections
  
• Fuzeon Viral Decay Pilot Study
  ClinicalTrials.gov Identifier: NCT00334022 - Active, not recruiting
  HIV-1
  
• Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
  ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
  Posthepatitic Cirrhosis